TSS:Rfhg 70557.1

Basic information about the TSS

---

TSS ID: rfhg_70557.1 Species: human Chr: chr5		Start: 102865806 End: 102865824 Strand: +
Source datasets	PRJNA4843412|DRA013844
Protocol	NETCAGE|CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3737905,EH38E2395186)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000513648.5:0 ENST00000345721.6:0 ENST00000346918.7:0 BC018127:0 GeneID: 5066 HGNC/MGI_ID: HGNC:8596 UniProt_ID: F8W8D9 P19021 Nearer transcript ids and distances: ENST00000509523.2:-69 M37721:186 AK296521:233 AK290158:261 S75037:292 S75038:292 ENST00000509832.5:-327 AB527419:371 BT007419:372 AB095007:372 ENST00000506006.1:-496 view more...

Gene_name: peptidylglycine alpha-amidating monooxygenase Gene_symbol: PAM Gene_synonyms: PAL PHM Gene_source: HGNC:8596

TATA-Box annotation

---

Distance to TSS:	-8
Nearest PromoterID:	NM_001177306
Entrez ID:	5066
Nearest Unigene:	Hs.369430
Nearest Refseq:	NM_000919
Nearest Ensembl:	ENSG00000145730
Gene Name:	peptidylglycine alpha-amidating monooxygenase
Gene Alias:	PAL|PHM
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.368421
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PAM p2@PAM p3@PAM p4@PAM p5@PAM p6@PAM p7@PAM p8@PAM p9@PAM p10@PAM
Sample		p1@PAM	p2@PAM	p3@PAM	p4@PAM	p5@PAM	p6@PAM	p7@PAM	p8@PAM	p9@PAM	p10@PAM
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.81	2.34	3.12	0.58	0.58	0.00	0.78	0.78	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.96	2.83	3.84	1.62	0.61	0.00	1.21	0.40	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	13.50	2.12	2.70	0.58	0.58	0.00	0.77	0.19	0.77	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.68	3.53	3.53	1.87	0.42	0.62	1.25	0.83	0.42	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	10.57	3.60	2.25	1.80	1.35	0.00	1.12	0.22	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.66	3.29	2.91	1.16	0.39	0.00	0.39	0.00	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.98	3.92	0.65	2.18	1.09	0.00	0.44	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	12.35	3.15	0.97	1.45	1.21	0.00	0.48	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	15.60	1.92	2.35	1.28	1.07	0.85	0.43	0.85	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	7.54	0.58	1.16	1.74	1.16	0.58	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.51	1.62	1.62	0.40	0.81	0.40	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	9.35	1.22	0.81	0.41	0.41	0.41	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	162.00	3.55	1.45	0.32	0.48	0.00	0.97	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	136.37	2.71	1.20	0.90	1.35	0.00	0.60	0.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	130.85	1.76	1.54	0.88	0.00	0.00	0.22	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	126.25	3.02	1.26	1.26	1.26	0.00	0.00	1.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	112.48	1.09	0.66	0.00	1.09	0.00	0.00	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	128.65	2.95	0.84	1.69	0.42	0.42	0.00	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	126.89	2.13	1.60	0.53	1.60	0.00	0.00	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	143.67	3.01	2.41	0.60	1.05	0.00	0.45	1.05	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	128.17	1.87	0.80	0.67	0.40	0.00	0.00	0.80	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	130.85	2.07	1.38	0.86	0.86	0.00	0.86	0.69	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	109.74	1.81	1.16	0.39	1.16	0.00	0.39	1.16	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	119.64	0.73	1.46	0.97	0.73	0.00	0.49	1.21	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	135.96	2.06	0.77	0.77	0.52	0.00	0.77	1.03	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	132.62	4.11	0.32	0.63	1.58	0.00	0.00	1.27	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	131.87	1.10	0.00	0.00	1.65	0.00	0.55	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	147.11	2.12	1.89	1.65	0.94	0.00	0.71	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	139.39	2.42	0.16	0.48	0.48	0.00	0.32	1.13	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	133.37	3.26	1.45	1.99	0.54	0.00	0.36	0.72	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	129.37	2.93	1.05	1.05	0.63	0.00	0.21	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	138.92	2.74	2.15	0.39	0.59	0.00	0.59	0.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	128.09	1.27	1.06	0.63	1.06	0.00	0.00	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	107.54	1.65	0.82	1.15	0.49	0.00	0.33	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	105.46	2.24	1.31	1.31	0.93	0.00	0.75	0.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	118.81	2.49	1.92	0.38	0.96	0.00	0.77	0.77	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	113.64	1.64	0.61	0.61	0.41	0.00	0.41	1.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	106.59	2.62	1.01	0.20	0.20	0.00	0.00	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	120.47	0.81	2.16	0.54	0.27	0.00	1.62	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	105.87	0.96	0.72	0.72	0.24	0.00	0.48	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	103.98	1.65	2.59	0.71	0.47	0.00	0.71	0.94	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	102.48	2.20	1.17	1.17	0.00	0.00	0.15	0.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	110.93	3.37	1.05	0.00	0.42	0.00	0.42	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	125.00	2.10	1.57	0.87	0.35	0.00	0.17	0.70	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	113.64	3.01	1.41	0.00	0.20	0.00	0.20	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	122.37	1.63	1.40	0.70	0.70	0.00	0.23	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	130.03	2.64	1.20	0.72	0.48	0.00	0.24	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	124.58	2.98	1.19	1.49	0.60	0.00	0.30	0.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	116.58	2.15	1.20	0.72	0.48	0.00	0.24	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	122.73	2.22	0.81	0.40	0.20	0.00	0.20	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	113.75	3.28	0.61	0.82	1.64	0.00	0.00	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	111.85	3.56	1.78	0.67	1.78	0.00	0.67	1.33	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	89.42	1.06	2.48	0.35	2.13	0.00	1.42	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	74.56	1.66	0.66	0.00	0.33	0.00	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	50.34	0.00	0.84	1.68	0.84	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	75.32	1.38	0.46	1.38	0.46	0.00	0.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	80.38	1.94	1.62	0.00	0.65	0.00	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	87.04	2.57	2.57	1.28	0.64	0.00	0.64	0.96	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	73.87	0.94	0.31	0.63	0.31	0.00	0.00	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	65.57	2.82	0.00	1.41	1.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	58.32	2.24	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	56.53	2.39	0.00	1.59	0.00	0.00	0.00	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	60.82	0.00	0.34	0.68	0.00	0.00	0.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	69.86	2.92	0.65	0.32	0.00	0.00	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	50.05	2.84	1.06	0.00	0.35	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	63.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	47.78	0.98	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	61.98	2.48	0.50	0.99	0.00	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	52.07	0.94	0.00	0.47	0.94	0.00	0.94	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	69.22	1.66	1.66	1.99	0.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	63.72	1.55	1.55	0.93	1.86	0.00	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	73.07	2.45	2.14	0.92	0.31	0.00	0.31	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	79.51	25.34	10.45	9.66	12.83	0.00	1.43	4.59	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	65.45	15.40	4.65	3.69	4.65	0.00	0.48	2.25	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	80.15	13.74	4.83	5.22	8.27	0.00	1.27	3.69	0.89	0.51
Adipocyte - omental, donor2	11474-119C7	68.02	20.93	11.96	6.73	5.98	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	66.31	16.75	2.01	5.36	9.71	0.00	1.34	1.00	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	145.46	11.48	5.10	0.64	2.55	0.00	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	0.00	0.00	0.00	1.10	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	32.52	8.13	1.35	1.35	4.97	0.00	0.45	2.26	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	35.10	6.43	3.82	1.91	3.30	0.00	0.00	0.35	0.17	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	106.20	15.84	11.73	5.08	3.91	0.00	1.56	3.32	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	41.70	3.60	2.57	2.06	1.03	0.00	0.51	1.54	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	86.70	15.33	11.71	8.92	6.41	0.00	2.23	3.07	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	75.83	19.99	4.11	10.58	7.05	0.00	0.00	2.94	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	62.98	8.77	2.49	2.17	6.03	0.00	0.48	1.45	2.09	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	44.22	10.01	2.26	1.29	4.20	0.00	1.29	3.23	1.94	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	64.52	13.86	5.33	3.73	4.80	0.00	0.53	5.87	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	55.09	14.47	0.56	2.23	8.35	0.00	0.56	4.45	1.67	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	42.84	8.32	3.33	2.08	2.50	0.00	0.83	0.42	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	38.43	6.03	0.75	0.25	3.77	0.00	1.00	0.75	1.26	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	50.40	11.45	0.98	2.62	8.51	0.00	0.65	1.64	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	35.93	10.05	2.74	1.22	4.57	0.00	0.30	0.30	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	25.19	1.10	1.33	0.22	0.44	0.00	0.22	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	10.40	0.36	0.36	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	53.79	0.72	0.18	0.54	0.00	0.00	0.18	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	41.84	0.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	39.86	0.62	0.21	0.21	0.00	0.00	0.00	0.21	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	67.97	7.90	4.12	3.43	1.83	0.34	0.34	1.60	0.69	0.46
Anulus Pulposus Cell, donor2	11463-119B5	64.17	9.55	0.98	1.71	1.71	0.00	0.00	0.49	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	40.44	29.20	14.83	5.84	7.64	0.00	2.25	2.25	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	35.60	31.69	9.99	6.51	3.47	0.00	2.60	1.30	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	23.54	8.56	4.28	2.14	0.00	2.14	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	34.97	28.40	8.97	9.27	7.77	0.00	2.69	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	29.09	32.88	5.06	8.85	5.06	0.00	0.00	3.79	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.98	29.70	9.24	7.26	5.28	0.00	2.64	2.64	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.81	24.04	9.10	8.45	5.52	0.00	2.92	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	42.23	36.41	10.68	5.83	7.77	0.00	3.40	1.46	0.49	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.13	24.94	10.69	7.13	3.56	0.00	1.19	1.19	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	44.44	22.22	8.66	9.04	3.39	0.00	1.88	1.88	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	44.27	9.43	5.81	3.63	0.73	0.73	0.73	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	30.09	45.14	8.78	6.27	10.03	0.00	0.00	5.02	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	48.10	36.90	14.33	8.07	4.78	0.00	2.80	0.99	0.16	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	46.40	9.55	4.09	0.00	0.00	5.46	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	47.80	39.66	16.29	11.01	6.94	0.00	2.11	1.81	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	37.51	33.75	9.11	4.82	2.68	0.00	1.07	1.61	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	41.00	31.74	14.55	7.56	6.05	0.00	2.08	1.89	0.57	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	39.56	31.27	9.62	10.96	5.88	0.00	3.21	1.34	0.00	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	45.85	34.14	11.71	7.80	3.90	0.00	1.95	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	33.50	25.54	11.61	6.14	6.97	0.00	2.16	1.66	0.00	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	28.82	27.62	6.00	8.41	9.61	0.00	1.20	2.40	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	70.80	10.62	10.62	14.16	0.00	7.08	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	43.74	27.79	12.01	7.55	5.66	0.17	1.72	1.20	0.00	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	33.56	4.19	12.58	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	39.32	32.04	7.77	5.83	4.37	0.00	3.40	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	40.22	28.08	14.80	4.55	4.17	0.00	2.28	2.28	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	48.45	43.61	4.85	6.06	4.85	0.00	1.21	2.42	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	41.61	25.08	7.41	6.27	3.99	0.00	0.57	0.57	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.07	34.42	11.33	8.76	5.77	0.00	2.14	1.07	0.00	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	27.87	38.20	9.55	6.97	5.42	0.00	2.32	0.26	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	36.60	23.93	7.04	7.04	6.57	0.00	1.88	1.41	0.47	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.08	24.76	12.22	7.72	9.00	0.32	1.61	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	32.82	28.54	9.27	4.99	4.99	0.00	0.71	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	34.51	26.91	8.77	7.60	1.75	0.58	1.75	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.52	31.61	13.55	6.62	3.61	0.00	2.41	0.90	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	32.08	32.08	8.32	10.69	3.56	0.00	3.56	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	36.62	26.95	6.10	10.17	2.54	0.00	3.05	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.53	25.47	9.42	6.62	4.08	0.00	1.78	0.51	0.00	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	28.59	23.51	5.72	3.81	3.18	0.00	2.54	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	35.39	28.05	6.90	9.49	6.04	0.43	3.45	0.86	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	34.29	29.85	9.53	5.50	4.45	0.00	1.91	0.42	0.00	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	34.51	23.78	5.80	4.64	4.93	0.00	1.16	1.45	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	42.51	26.45	10.39	9.45	3.78	0.00	1.89	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	42.04	28.65	11.53	6.78	7.29	0.00	1.70	1.86	0.00	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	20.85	9.27	0.00	11.58	0.00	0.00	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	46.48	8.45	14.79	8.45	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	34.73	29.80	9.43	7.93	6.00	0.00	3.43	0.64	0.21	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	32.49	9.02	7.22	6.62	0.00	1.80	1.20	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	40.82	29.89	8.75	8.02	2.92	0.00	2.19	2.19	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	38.39	23.91	8.51	9.20	5.06	0.00	1.15	1.38	0.23	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	20.40	2.55	7.65	5.10	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	58.73	36.61	14.75	12.97	7.12	0.00	1.02	1.53	0.00	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	37.37	34.89	11.56	7.02	2.89	0.00	2.48	0.62	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	31.52	33.35	7.96	10.10	4.28	0.00	2.14	2.75	0.31	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	49.24	26.29	10.04	9.08	1.91	0.00	1.43	0.48	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.02	22.84	10.42	9.53	4.43	0.00	0.89	1.55	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	41.20	16.78	12.21	1.53	7.63	0.00	4.58	4.58	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	41.54	26.59	9.42	7.20	6.09	0.00	4.43	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.90	26.21	12.18	7.41	3.71	0.00	2.38	0.79	0.26	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	37.44	32.71	10.54	6.91	4.00	0.00	2.54	0.36	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	20.76	2.33	1.47	1.60	0.49	0.12	0.37	1.23	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	14.89	3.08	1.54	0.68	0.34	0.00	0.34	0.86	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	24.33	1.05	0.00	0.21	0.21	0.00	0.00	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	69.72	3.14	8.02	4.88	1.74	0.70	0.70	0.70	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	46.11	9.06	7.60	8.74	1.94	0.32	2.43	1.29	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	44.15	3.88	4.77	3.43	0.60	0.00	0.75	1.04	0.75	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	32.91	0.11	0.00	0.00	0.11	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.17	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	19.69	0.23	0.00	0.00	0.11	0.00	0.00	0.11	0.00	0.00
Basophils, donor1	12241-129G9	6.02	5.23	2.62	2.88	0.52	0.00	0.00	0.00	0.52	0.00
Basophils, donor2	12242-129H1	16.96	5.41	5.77	2.16	1.44	0.00	0.36	0.36	0.00	0.00
Basophils, donor3	12243-129H2	12.64	6.32	4.56	1.76	2.06	0.00	0.44	0.73	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	25.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	7.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	20.59	0.21	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	17.50	0.00	0.00	0.23	0.00	0.00	0.00	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	22.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	19.83	3.20	0.00	0.00	0.64	0.00	0.32	0.32	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.78	10.14	1.69	1.69	1.69	0.00	1.13	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	11.69	7.80	3.53	2.41	2.60	0.00	0.00	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	11.64	3.51	1.98	1.98	2.41	0.00	0.88	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	29.44	1.70	0.00	0.00	0.57	0.00	0.00	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	19.33	1.90	0.38	0.00	0.76	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.67	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	7.37	0.14	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	3.62	3.02	0.91	0.00	1.51	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	5.45	1.42	0.47	0.47	0.47	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.85	0.17	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	10.49	2.21	1.66	1.93	0.00	0.28	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.21	5.45	2.23	0.74	0.74	0.00	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.50	0.00	0.00	0.00	0.20	0.00	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.99	7.66	2.67	1.07	1.60	0.00	0.18	0.00	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.18	4.57	1.96	0.65	1.31	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.85	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	24.82	3.17	2.64	6.34	0.00	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	12.20	2.22	0.00	3.33	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	7.29	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.39	6.59	2.59	0.20	1.80	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	7.91	6.25	0.62	0.42	1.04	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	0.69	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.11	15.38	3.39	1.81	4.52	0.00	0.45	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	10.91	2.18	0.00	3.06	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.98	4.01	0.70	0.52	1.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	13.47	2.10	1.26	0.42	0.42	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.96	0.37	0.18	0.00	0.18	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.47	5.28	1.06	1.06	1.41	0.00	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	2.19	0.44	0.00	1.75	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.28	0.52	0.00	0.52	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	14.50	2.97	2.97	3.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.92	9.92	1.72	1.72	1.94	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	0.82	0.00	0.41	0.82	0.00	0.00	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.71	1.85	2.09	0.70	1.62	0.00	0.00	0.23	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.50	2.32	0.46	0.46	2.09	0.00	0.00	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	3.71	1.74	0.22	0.00	0.87	0.00	0.00	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	4.39	1.85	0.46	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	3.03	0.22	0.00	0.00	0.43	0.00	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.64	1.25	0.00	0.16	0.16	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	14.32	0.70	0.35	0.35	0.17	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	8.25	0.45	0.00	0.00	0.22	0.00	0.00	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	2.55	0.51	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	4.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	1.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	3.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	0.00	0.00	0.00	0.00	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.29	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	3.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.81	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	9.04	0.00	1.00	0.00	0.00	0.00	0.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	8.43	2.25	1.12	0.56	1.12	0.00	1.69	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	12.02	0.38	0.00	0.38	0.00	0.00	0.00	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	16.01	1.35	0.00	0.68	0.45	0.00	0.00	0.00	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	29.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	26.94	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	25.01	0.00	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	27.18	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	27.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	34.41	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	22.37	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.69	0.00	0.45	0.00	0.00	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	54.50	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	37.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	25.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	14.13	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	17.40	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	18.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.44	0.00	0.00	0.19	0.19	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.23	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	27.32	0.84	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	32.86	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	57.19	0.00	0.00	0.00	0.00	0.00	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	33.65	0.00	0.00	0.00	0.00	0.00	0.00	0.49	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	1.40	0.00	1.40	0.00	0.00	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	40.71	1.38	0.28	0.83	0.55	0.00	0.00	0.28	0.55	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	38.28	1.72	0.49	0.00	0.74	0.00	0.25	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	27.58	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	31.85	0.00	0.00	0.00	1.38	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	45.51	0.65	3.27	2.62	1.31	0.00	0.65	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	39.04	4.51	3.75	6.76	1.88	0.00	1.13	1.50	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	25.00	1.26	2.52	1.26	0.76	0.00	0.76	0.50	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.70	2.75	1.38	0.23	5.28	0.00	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.90	2.16	0.48	0.00	5.75	0.00	0.00	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.40	2.46	0.00	0.00	4.38	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.91	3.30	1.20	0.00	3.90	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.72	4.32	0.00	0.00	4.80	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.42	5.23	1.14	0.23	7.28	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.12	1.30	0.22	0.22	4.13	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.37	1.05	0.53	0.00	2.37	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.31	0.94	0.47	0.00	3.05	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.68	3.32	0.30	0.00	4.23	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.85	1.16	0.29	0.00	1.74	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	14.39	1.60	0.00	0.00	1.07	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	24.08	8.32	6.13	1.31	10.51	0.00	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.76	6.83	5.47	0.00	6.83	0.00	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	18.65	7.46	5.22	1.49	7.46	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.57	5.04	1.08	0.00	7.20	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.93	4.60	1.15	0.29	8.63	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.03	3.77	0.94	0.47	7.07	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	14.89	1.90	0.63	0.00	2.22	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	18.76	1.23	0.92	0.00	2.46	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.03	0.96	0.32	0.32	2.56	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	18.36	1.53	0.76	0.38	3.06	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.34	1.58	0.39	0.00	6.31	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	5.29	0.00	0.00	3.78	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	37.74	16.86	8.83	0.80	27.30	0.00	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.77	20.28	6.29	1.40	23.78	0.00	0.70	0.00	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	18.03	13.02	1.00	29.05	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	1.83	0.00	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	15.32	8.89	3.95	3.46	0.99	0.00	0.49	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	80.08	1.58	1.58	1.37	0.11	0.00	0.00	0.53	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	46.11	28.08	17.33	7.97	5.20	0.00	0.69	0.35	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	76.76	4.62	1.78	0.71	2.84	0.00	0.71	0.36	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	66.79	27.08	10.35	6.83	8.08	0.00	1.82	1.59	1.02	0.57
Chondrocyte - re diff, donor2	11339-117F7	150.40	4.48	1.79	0.00	3.58	0.00	0.90	0.90	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	160.95	3.64	0.81	1.62	1.21	0.00	0.00	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	55.20	5.05	2.41	2.18	1.03	0.00	1.72	2.64	0.69	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	43.39	2.57	1.28	1.92	0.86	0.00	0.43	1.07	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	37.79	2.65	1.24	2.48	1.33	0.00	0.27	1.50	0.27	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	71.53	8.34	3.03	1.47	3.94	0.64	0.00	2.29	2.38	0.18
Corneal Epithelial Cells, donor1	11526-119I5	9.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.24	23.11	1.32	0.83	19.48	0.00	0.50	0.83	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.76	19.24	1.26	1.89	20.19	0.00	0.63	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	10.35	0.00	0.00	17.25	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.60	26.57	3.56	1.94	32.18	0.00	0.86	0.54	0.32	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	9.91	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	8.23	0.97	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	35.86	2.84	1.83	1.67	0.67	0.00	0.33	0.33	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	4.69	0.00	1.76	0.59	0.00	0.00	0.59	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	50.34	2.55	0.57	0.57	0.28	0.00	0.28	0.00	0.00	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	33.42	6.68	1.18	0.79	1.18	0.00	0.00	0.00	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	28.80	4.94	0.58	1.16	0.58	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	28.94	2.59	0.47	0.24	0.24	0.00	0.24	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	29.80	4.21	0.88	0.53	0.70	0.00	0.18	0.35	0.00	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	89.33	3.99	0.89	0.44	1.55	0.00	0.00	0.66	0.00	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	101.02	7.91	0.30	0.61	1.52	0.00	0.00	0.91	1.22	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	135.60	5.64	1.13	0.56	1.13	0.00	0.28	1.41	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	37.44	2.67	0.30	0.59	0.00	0.00	0.00	0.00	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	41.13	4.69	0.52	0.52	0.00	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	32.89	1.28	0.28	0.28	0.57	0.00	0.00	0.28	0.14	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	46.81	2.40	0.80	1.20	0.80	0.00	0.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	1.57	0.52	0.00	0.52	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	80.39	5.84	1.37	1.86	0.99	0.00	0.25	0.75	0.12	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	42.15	3.69	0.65	0.43	0.65	0.00	0.43	0.22	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	47.39	5.37	0.73	0.61	1.34	0.00	0.49	0.73	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	25.03	3.41	0.00	1.14	1.14	0.00	0.00	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	50.99	0.70	0.70	3.49	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	37.05	1.88	1.10	1.26	0.31	0.00	0.16	0.16	0.00	0.16
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.73	0.00	0.00	0.24	0.00	0.00	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	91.13	27.09	10.26	7.39	9.44	0.00	2.46	2.05	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	66.35	36.90	8.76	7.55	11.28	0.11	2.63	1.42	0.22	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.19	10.73	2.28	1.63	4.77	0.00	0.33	1.30	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	39.54	30.44	7.03	3.15	8.13	0.00	0.73	0.36	0.12	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	85.43	48.45	19.79	8.73	9.55	0.00	1.77	1.50	0.27	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	54.53	23.31	9.39	6.43	7.49	0.00	2.11	1.05	0.42	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	88.80	179.96	33.20	10.80	40.31	0.00	4.48	2.11	0.00	6.06
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.23	55.48	12.96	5.32	11.29	0.00	2.33	0.66	1.00	1.66
Fibroblast - Cardiac, donor1	11268-116G8	53.98	46.27	15.88	8.17	10.89	0.00	2.72	0.91	0.00	1.81
Fibroblast - Cardiac, donor2	11345-117G4	29.56	6.06	1.52	0.00	0.76	0.00	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	26.02	8.99	3.79	2.68	2.05	0.00	0.79	0.63	0.00	0.79
Fibroblast - Cardiac, donor4	11452-119A3	53.35	30.31	10.00	9.09	9.40	0.00	1.21	1.21	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	50.25	6.22	3.43	1.90	0.76	0.00	0.76	1.02	0.00	0.51
Fibroblast - Cardiac, donor6	11460-119B2	45.63	15.46	4.24	3.18	3.49	0.00	0.15	0.61	0.00	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	39.13	4.42	1.34	1.74	1.21	0.00	0.54	2.55	3.35	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.93	5.61	2.16	0.00	2.59	0.00	0.43	5.18	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	1.46	0.00	2.93	0.00	1.46	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.60	6.92	5.07	4.61	0.92	0.46	0.69	0.46	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	71.91	21.71	16.79	10.01	8.14	0.17	7.97	10.35	8.31	1.19
Fibroblast - Dermal, donor1	11269-116G9	50.24	10.80	6.57	4.70	3.29	0.00	0.00	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	29.72	8.02	4.25	2.36	1.42	0.00	0.94	0.00	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	55.00	18.74	10.52	8.34	6.77	0.00	1.45	1.33	0.24	0.48
Fibroblast - Dermal, donor4	11450-119A1	33.57	24.30	30.52	24.08	2.71	1.13	4.18	1.36	0.23	0.45
Fibroblast - Dermal, donor5	11454-119A5	28.26	23.90	15.53	15.88	4.36	0.87	3.14	1.92	0.35	1.22
Fibroblast - Dermal, donor6	11458-119A9	27.12	24.36	20.14	16.89	1.46	1.14	4.87	1.79	0.00	1.30
Fibroblast - Gingival, donor1	11237-116D4	74.13	7.08	5.62	5.83	1.04	0.00	0.83	1.67	1.04	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	58.69	24.10	7.60	6.55	6.29	0.00	0.79	2.10	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	23.98	3.29	1.58	0.66	0.53	0.00	0.66	0.40	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	73.10	12.76	6.86	5.70	2.90	0.00	0.87	1.84	0.39	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	74.80	2.08	3.12	0.00	3.12	0.00	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	44.40	9.16	3.88	2.64	2.11	0.00	0.18	1.23	0.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.79	12.00	2.81	2.96	3.90	0.00	0.78	1.25	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.80	6.49	0.95	0.81	1.35	0.00	0.41	0.41	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	51.17	9.88	5.65	3.88	2.12	0.00	2.82	1.76	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.49	17.99	5.70	5.41	5.85	0.00	0.73	1.17	0.44	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	25.50	17.73	6.68	6.95	4.91	0.00	0.95	1.23	0.00	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	29.29	16.45	5.92	5.05	3.84	0.00	0.00	0.33	0.22	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	94.35	31.11	11.30	9.68	6.90	0.00	2.05	4.84	1.76	0.88
Fibroblast - Lung, donor1	11270-116H1	23.11	0.00	9.52	5.44	2.72	0.00	0.00	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	53.72	11.94	8.95	4.48	8.95	0.00	1.49	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	37.78	11.18	8.65	3.38	4.22	0.21	0.63	0.63	0.21	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	24.99	2.50	0.00	2.50	0.00	0.00	0.00	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	1.40	2.80	0.00	0.00	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.72	0.84	0.28	0.28	0.00	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	50.75	4.47	0.00	2.44	0.41	1.22	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	0.00	5.96	5.96	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	28.90	7.18	4.66	5.04	1.16	0.00	0.97	1.16	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	32.00	5.01	2.58	2.43	0.76	0.00	1.06	1.52	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	78.64	3.98	5.20	2.14	0.92	0.00	0.92	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.83	13.74	7.63	1.14	3.05	0.00	0.76	1.53	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.32	19.44	7.83	5.13	5.94	0.00	0.54	1.35	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	73.64	23.54	11.02	6.49	6.84	0.00	1.28	1.86	0.35	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	38.02	15.14	4.20	1.11	3.32	0.11	0.77	0.11	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.91	1.22	0.41	0.41	0.41	0.00	0.00	0.20	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.03	3.34	1.34	1.34	0.00	0.00	0.00	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	30.44	7.91	3.95	4.35	1.58	0.00	1.19	1.58	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	52.59	71.44	31.35	26.59	12.50	0.20	4.76	3.37	0.20	3.57
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	114.92	30.91	27.89	21.14	12.61	0.00	2.49	3.02	2.31	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	113.13	14.58	9.85	7.10	5.52	0.00	1.58	1.18	0.79	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	82.74	129.97	39.11	21.36	26.78	0.30	7.22	1.50	0.90	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	97.16	57.54	24.72	17.49	13.28	0.00	7.02	2.48	2.48	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	69.60	63.52	18.98	6.83	11.89	0.25	6.58	2.78	1.27	1.27
Fibroblast - skin normal, donor1	11553-120C5	86.96	60.05	31.01	11.32	13.29	0.33	8.53	3.77	2.95	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	75.79	118.10	45.52	25.06	25.26	0.20	6.22	2.01	0.60	1.80
Fibroblast - skin normal, donor2	11561-120D4	59.57	71.43	22.60	17.18	17.98	0.00	5.22	1.51	0.70	1.81
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	69.82	76.47	29.01	21.46	15.41	0.00	3.63	1.81	1.21	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	123.61	29.58	19.72	18.06	8.86	0.00	2.98	5.88	3.07	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	96.59	46.84	21.54	14.87	13.85	0.00	7.52	13.33	6.67	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	115.61	188.19	39.74	16.09	40.40	0.33	10.51	4.27	2.30	7.88
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	81.28	55.18	17.47	9.80	9.27	0.11	5.75	2.45	1.49	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	54.15	31.37	15.86	15.86	10.12	0.00	1.86	0.51	0.17	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	45.32	17.25	5.96	6.74	4.23	0.31	5.49	2.67	1.10	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.12	2.61	3.49	2.61	6.97	0.00	0.87	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	56.51	0.00	0.17	0.00	0.00	0.00	0.35	0.52	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	67.14	0.00	0.00	0.00	0.78	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	55.19	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.08	0.00	0.00	0.00	0.77	0.77	0.00	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	0.64	1.28	0.00	0.00	0.00	1.28	2.55	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.67	1.43	1.14	2.57	0.29	0.57	0.86	2.28	2.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	47.43	7.45	12.41	12.13	2.76	1.65	1.10	4.14	10.75	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.33	5.25	4.34	5.02	2.28	4.34	1.37	4.11	2.74	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	37.25	2.97	3.96	4.16	0.59	0.59	1.39	4.36	3.37	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.35	7.14	13.22	10.04	3.97	0.53	1.06	4.49	11.37	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	35.88	8.81	6.52	3.26	3.59	4.24	1.96	2.94	1.96	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	41.57	1.77	1.33	1.33	0.00	0.44	1.33	2.21	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	21.90	0.85	1.27	1.98	0.28	0.57	0.71	1.41	1.70	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.87	4.68	3.32	6.16	0.12	0.62	1.60	2.22	2.96	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	13.43	0.54	2.69	1.07	0.81	0.00	0.81	0.54	2.15	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.40	6.57	7.43	6.69	1.12	1.49	2.11	1.61	1.24	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	22.15	4.29	10.80	9.41	0.83	0.69	2.08	1.25	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.82	4.07	2.44	4.47	0.81	0.20	1.02	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	25.33	7.30	9.58	8.21	3.65	1.14	2.28	2.05	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.64	9.34	11.34	10.21	2.62	1.12	3.36	1.62	1.62	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	24.92	4.37	6.12	6.34	1.31	0.44	1.97	0.44	0.87	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.73	10.34	7.98	7.09	3.55	1.48	1.18	1.48	5.32	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.69	9.54	10.49	7.15	2.70	1.43	2.86	1.91	2.86	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	26.36	9.38	6.70	4.02	2.46	0.00	0.22	1.79	1.34	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	35.08	9.68	6.25	6.05	4.03	1.01	1.61	3.02	3.43	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	48.18	13.74	11.37	10.86	3.73	1.87	4.24	2.71	3.39	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	40.26	11.44	7.45	7.09	4.88	5.50	2.13	1.95	2.84	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.07	12.07	9.16	4.79	4.68	1.56	0.52	2.19	1.66	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.60	10.76	8.20	5.46	4.95	1.37	1.37	2.39	2.73	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.77	14.50	7.41	5.64	6.20	1.22	1.33	1.33	1.55	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.01	12.90	7.49	4.91	6.07	5.07	1.00	1.50	2.75	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.74	15.11	7.55	5.72	5.10	3.68	0.41	2.25	3.88	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.29	10.52	6.40	5.57	4.13	1.44	1.44	1.86	1.03	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	59.03	13.14	7.61	5.53	4.84	0.81	1.15	1.96	2.54	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.19	26.52	11.84	6.84	10.84	1.50	1.00	0.83	1.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.25	11.24	5.73	4.19	5.51	1.10	0.44	2.42	1.76	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.23	13.78	5.78	4.06	6.89	0.74	0.98	1.23	0.86	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.33	25.77	10.05	3.08	12.32	4.86	1.30	1.95	1.78	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.58	13.79	9.62	3.21	8.98	1.28	0.96	0.64	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	55.15	19.80	9.19	7.30	8.34	3.03	1.71	1.80	1.61	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.55	31.95	12.50	6.17	15.82	1.42	0.95	1.74	0.63	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	39.53	19.16	10.34	8.51	9.12	1.82	0.30	1.52	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	48.92	14.11	8.36	7.84	6.27	2.93	1.99	1.25	0.73	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.79	57.08	13.83	6.59	26.57	2.85	0.66	0.88	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	46.57	17.11	12.62	8.14	7.29	1.96	1.96	0.84	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.13	40.55	19.72	14.07	16.94	0.28	3.15	1.67	1.85	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.40	57.76	18.18	12.30	26.47	1.87	1.87	1.34	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	21.42	54.47	20.66	10.71	29.38	0.92	2.30	1.38	0.77	1.84
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.03	47.93	21.76	16.32	17.88	0.52	4.15	1.55	2.20	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.82	90.54	21.41	10.84	43.10	0.81	1.90	1.63	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	36.69	23.97	14.75	11.98	11.25	0.55	1.66	2.77	1.84	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.50	18.86	15.57	10.31	10.09	0.66	1.97	4.61	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	38.68	61.49	20.83	7.93	24.79	0.00	2.98	1.98	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	42.48	25.99	18.20	13.98	10.82	0.13	3.69	5.01	2.64	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	53.47	34.10	24.21	15.54	13.92	0.40	4.84	3.63	2.22	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	58.46	17.28	13.72	6.35	10.93	1.02	0.76	4.07	4.57	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	21.70	0.80	0.60	1.39	0.00	0.00	0.80	1.59	5.37	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.41	0.77	0.46	1.23	0.31	0.00	0.31	1.54	2.62	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	21.89	0.82	1.43	0.82	0.00	0.00	0.61	2.25	8.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.71	0.63	1.25	1.25	0.31	0.31	0.31	0.94	4.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.58	0.00	0.85	0.00	0.00	0.00	0.00	0.57	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.53	0.00	0.46	0.00	0.00	0.00	0.00	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	2.47	7.42	0.00	0.00	0.00	2.47	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.70	3.48	2.71	1.55	0.39	0.39	2.32	1.16	4.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	8.02	6.42	6.42	1.60	0.00	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	20.87	1.74	3.48	5.22	0.00	3.48	0.00	3.48	6.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	13.67	1.30	1.95	0.98	0.98	0.33	0.65	1.63	2.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	18.12	3.71	1.65	3.71	0.00	0.41	1.24	1.24	2.47	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	10.00	3.33	0.00	0.00	0.00	0.00	10.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	20.41	3.36	2.24	1.12	1.12	0.00	0.56	0.84	2.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.40	2.29	3.27	1.63	0.98	0.00	0.33	1.31	3.27	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	30.20	1.68	3.36	0.84	0.84	0.00	0.84	0.84	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	26.72	4.13	6.04	2.23	1.91	0.32	1.59	2.23	2.86	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.57	2.72	3.06	0.68	1.36	0.34	1.02	2.04	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	29.23	10.44	0.00	0.00	0.00	0.00	2.09	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.64	4.58	4.58	0.57	2.29	0.00	0.00	1.15	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.39	4.44	4.14	2.37	1.78	0.30	0.59	1.78	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	10.16	5.08	5.08	1.69	0.00	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	18.23	7.04	7.87	2.49	1.24	0.00	3.31	1.24	1.66	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	25.31	5.52	6.67	2.30	2.30	0.69	0.69	0.92	2.07	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	5.27	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	20.37	5.38	3.08	2.31	3.08	1.54	0.38	1.15	2.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	21.84	6.52	5.54	2.93	0.65	0.00	0.65	1.63	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.77	5.35	4.01	2.68	2.68	0.00	0.00	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.49	4.24	3.08	3.08	0.77	0.39	0.39	1.54	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.44	7.53	5.48	4.11	1.37	2.40	2.40	2.40	1.37	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	2.48	7.45	4.97	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.39	4.72	5.19	0.94	1.89	0.47	0.47	0.47	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.33	3.62	4.83	2.41	0.00	0.60	1.21	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	40.19	3.05	1.02	0.51	0.51	1.53	0.51	2.54	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	37.09	5.58	4.79	1.20	2.79	0.40	0.40	1.99	3.19	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.12	3.45	2.96	0.49	0.49	0.99	0.99	0.49	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	8.26	3.54	1.18	2.36	0.00	0.00	2.36	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	37.92	7.58	3.50	1.17	0.00	1.17	1.17	1.17	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	24.14	2.63	0.88	0.44	0.88	2.19	0.44	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.95	6.78	7.63	3.39	0.00	0.00	1.70	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	27.46	13.73	20.89	8.95	6.57	0.00	2.39	0.00	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	22.81	7.28	11.16	2.91	1.46	0.49	1.46	0.49	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	42.23	4.57	2.28	0.00	1.14	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	39.92	21.62	10.40	7.07	4.99	0.00	1.66	1.66	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	10.12	1.12	3.37	3.37	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	41.23	3.81	2.54	0.95	2.54	0.00	0.63	0.63	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	58.90	12.53	6.27	2.92	3.76	0.42	0.00	1.25	0.42	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.08	2.67	1.16	1.97	0.81	0.00	0.23	0.58	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	23.46	2.87	2.87	1.52	0.84	0.00	0.34	0.17	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	20.25	2.73	0.91	1.59	0.91	0.00	0.23	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.53	3.06	1.31	1.53	1.09	0.00	0.55	0.11	0.11	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.71	4.94	3.01	1.93	1.93	0.00	0.43	0.00	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	25.83	3.01	2.37	2.37	2.37	0.00	0.86	0.65	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.56	3.74	1.12	2.37	0.87	0.00	0.62	0.75	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	17.84	4.63	1.54	1.54	1.20	0.00	0.17	0.51	0.17	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	20.18	3.52	1.92	1.60	0.64	0.00	0.32	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	45.89	4.48	0.56	0.00	0.56	0.00	0.00	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.98	1.73	1.30	0.87	0.87	0.00	0.00	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	10.58	0.00	0.00	2.64	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.35	3.53	0.35	0.00	1.06	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	12.35	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.79	2.62	1.57	0.52	1.05	0.35	0.17	0.00	0.00	0.35
Hepatocyte, donor1	11523-119I2	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	4.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	21.47	2.45	1.23	0.61	1.84	0.00	0.00	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.17	0.70	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	62.43	0.96	1.10	1.51	0.14	0.00	0.27	0.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	48.31	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	12.30	0.00	0.00	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	20.82	0.00	0.00	0.09	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	33.83	0.11	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor1	11527-119I6	17.88	1.38	2.75	2.75	0.00	0.00	0.69	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	0.00	1.17	1.17	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	27.27	3.16	1.38	1.78	1.38	0.00	0.00	0.79	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	43.96	24.18	13.19	19.78	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	1.08	0.00	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	65.05	5.31	7.50	5.07	1.15	0.12	1.15	1.85	0.46	0.35
Lens Epithelial Cells, donor3	11690-122I7	58.53	3.03	2.02	2.12	0.10	0.00	0.20	0.61	0.30	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	47.67	2.61	1.42	1.30	0.83	0.00	0.00	0.47	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.98	3.91	0.28	0.56	0.28	0.00	0.00	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	51.95	2.99	0.16	0.31	1.26	0.00	0.00	0.63	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	33.34	1.08	0.00	1.08	1.08	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	28.68	1.58	0.32	0.63	0.32	0.00	0.00	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.47	2.16	0.22	0.43	0.43	0.00	0.11	0.54	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.52	4.51	0.82	1.64	0.82	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	22.50	1.77	0.76	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.46	2.39	0.56	0.28	0.70	0.00	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	28.08	2.37	0.00	0.40	1.19	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.00	3.49	0.39	0.97	0.97	0.00	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.14	1.67	0.00	0.19	0.19	0.00	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	38.33	2.79	0.35	0.70	0.70	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	30.05	1.43	0.72	0.00	0.72	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.67	2.06	0.14	0.41	0.55	0.00	0.00	0.27	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	36.03	3.70	0.31	0.31	0.31	0.00	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.38	1.56	0.00	0.62	0.94	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.64	2.38	0.37	0.37	0.73	0.00	0.00	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	40.81	5.59	0.66	1.32	1.97	0.00	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.19	1.46	0.00	0.29	0.59	0.00	0.00	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.18	2.24	1.24	0.25	0.50	0.00	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.34	3.39	0.48	2.42	0.00	0.00	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.08	1.89	0.81	0.27	0.27	0.00	0.54	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	32.70	3.33	0.15	1.06	1.06	0.00	0.15	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	26.96	4.67	0.00	0.00	0.52	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	38.95	4.19	0.63	1.05	0.42	0.00	0.00	0.21	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.17	3.46	0.60	0.75	0.90	0.00	0.15	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	32.33	2.75	0.00	0.00	1.38	0.00	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	29.54	2.07	0.56	0.56	0.94	0.00	0.38	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.37	2.33	0.21	0.32	0.85	0.00	0.00	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	39.25	5.33	0.48	0.00	0.00	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.82	2.98	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.41	2.48	0.25	0.37	0.74	0.00	0.37	0.25	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	55.90	4.07	0.37	0.74	0.74	0.00	0.00	0.00	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	32.12	2.22	0.49	0.25	0.74	0.00	0.00	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	22.96	1.24	0.27	0.41	0.27	0.00	0.14	0.27	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	45.03	5.47	0.32	1.29	1.61	0.00	0.00	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.61	1.52	0.30	0.61	0.91	0.00	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	40.03	5.18	0.28	1.26	0.84	0.00	0.14	0.42	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	38.76	5.33	0.00	1.07	1.42	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.30	1.45	0.48	1.45	0.00	0.00	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.61	1.09	0.16	0.31	0.62	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	36.88	2.51	0.00	1.79	0.36	0.00	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	24.50	3.92	0.65	0.33	0.00	0.00	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.07	2.12	0.00	0.00	0.71	0.00	0.00	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	41.21	2.10	1.24	0.74	1.11	0.00	0.00	0.37	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.86	2.82	0.51	0.00	0.51	0.00	0.00	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.27	1.19	0.60	1.19	0.00	0.00	0.30	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.50	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	0.00	0.00	0.00	1.19	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.45	0.45	0.00	0.00	0.90	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.86	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	5.52	0.00	0.00	0.00	0.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.83	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	3.09	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	7.17	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	0.55	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.25	0.35	0.00	0.00	0.35	0.00	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.06	0.00	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.83	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5.10	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.13	0.00	0.00	0.00	0.45	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.74	0.00	0.00	0.37	0.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	6.40	0.00	0.00	0.00	0.00	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.38	0.00	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	4.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.34	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.44	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5.57	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.14	0.00	0.40	0.00	0.00	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.30	0.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.12	0.00	0.38	0.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	0.52	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7.92	0.00	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	0.00	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.31	1.54	0.51	0.00	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	0.00	0.42	0.00	0.00	0.00	0.42	0.83	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	8.35	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	0.00	0.00	0.00	0.00	0.00	0.00	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	0.00	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.00	0.26	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	23.02	2.05	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	15.23	3.30	0.73	0.18	4.04	0.00	0.18	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	17.30	1.44	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	89.05	0.32	0.00	0.32	0.00	0.00	0.16	0.16	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	65.32	0.14	0.14	0.00	0.00	0.00	0.14	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	41.25	0.20	0.10	0.00	0.10	0.00	0.20	0.20	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	31.27	0.29	0.29	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	25.19	0.25	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	12.20	2.71	1.36	0.68	1.36	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	4.33	0.87	0.22	0.00	0.43	0.00	0.00	0.11	0.00	0.11
Mast cell, donor2	11565-120D8	47.55	21.10	8.32	4.16	3.27	0.30	0.59	0.89	0.59	0.30
Mast cell, donor3	11566-120D9	57.63	7.43	1.80	0.45	2.48	0.00	0.23	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	42.73	11.70	3.90	1.60	2.48	0.18	0.00	0.35	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	57.78	2.99	0.78	0.67	2.33	0.00	0.22	0.22	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	31.52	12.84	0.00	0.00	2.92	0.00	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	7.80	1.15	0.11	0.00	0.57	0.11	0.11	0.11	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	7.03	2.34	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	53.53	3.98	0.60	0.00	0.99	0.00	0.20	0.50	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	16.61	8.31	4.15	2.77	2.08	0.00	0.35	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	21.51	42.52	10.94	4.13	24.34	0.00	0.36	0.14	0.07	0.22
Melanocyte - light, donor1	11274-116H5	31.73	31.03	8.70	4.23	14.10	0.00	0.47	0.24	0.24	0.24
Melanocyte - light, donor2	11351-117H1	15.70	27.98	5.46	2.05	23.20	0.00	0.68	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	13.01	1.73	0.00	0.87	1.73	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	30.61	9.48	3.23	0.62	5.83	0.10	0.00	0.42	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	0.81	2.96	0.27	0.27	3.23	0.00	0.00	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	16.61	8.84	1.34	0.80	12.32	0.00	0.00	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	33.37	2.61	2.98	3.60	0.74	0.00	1.12	1.36	0.50	0.37
Meningeal Cells, donor2	11573-120E7	50.62	7.04	3.96	3.08	3.08	0.00	1.76	1.32	0.44	0.44
Meningeal Cells, donor3	11654-122E7	32.93	5.30	3.75	5.05	1.06	0.00	1.14	2.61	0.33	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.65	3.99	1.71	2.28	0.57	0.86	0.29	1.43	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	42.27	6.24	3.12	1.51	2.01	0.30	1.01	1.61	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	1.31	0.00	0.00	1.31	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	2.62	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.81	7.89	3.59	1.44	0.72	0.00	0.00	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	98.68	10.80	5.51	4.45	3.60	0.00	1.06	3.18	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	81.93	9.55	3.52	5.53	6.03	0.00	1.01	1.51	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.53	1.76	0.22	0.44	0.22	0.00	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	1.46	0.00	0.00	0.00	0.00	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.59	0.61	1.43	0.82	0.00	0.00	0.00	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	97.37	3.74	2.22	1.66	1.25	0.14	0.69	0.55	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	17.47	2.97	0.74	0.37	1.49	0.00	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	132.50	1.84	1.05	1.58	0.79	0.00	0.13	1.18	0.39	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.87	1.48	0.59	0.30	0.59	0.59	0.30	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	1.92	0.64	1.28	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.38	9.92	7.44	4.96	3.19	0.00	0.00	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	109.14	1.56	0.63	0.63	0.63	0.00	0.00	0.31	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	16.69	0.73	0.73	0.00	0.00	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	152.48	10.34	4.77	2.12	3.18	0.00	1.06	0.53	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	83.08	6.51	4.00	2.50	2.00	0.00	1.50	1.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	79.13	5.28	2.96	2.46	1.01	0.00	0.58	0.43	0.00	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	4.05	0.00	1.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.73	7.14	0.74	0.74	6.16	0.00	0.00	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.97	17.08	0.88	1.47	15.61	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	10.37	0.00	0.00	20.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.16	6.51	0.00	0.31	3.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.69	13.28	1.24	1.04	9.96	0.00	0.41	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	2.32	0.00	0.00	9.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.77	6.26	0.25	0.00	5.51	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	10.71	1.86	0.93	13.03	0.00	0.00	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.31	3.45	0.20	0.61	4.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	21.38	14.25	1.19	1.98	13.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	7.96	0.88	0.00	4.42	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	13.68	9.50	0.38	0.38	14.06	0.00	0.00	0.38	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	3.95	0.00	2.63	3.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.82	3.82	0.42	0.85	2.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	11.05	0.00	0.92	6.45	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.22	5.66	1.19	0.00	2.98	0.00	0.30	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	5.03	0.00	1.68	6.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.79	4.77	1.76	0.50	3.26	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.21	10.70	2.61	0.24	8.56	0.00	0.24	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	2.76	0.00	0.00	3.32	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.81	4.14	1.84	0.46	5.30	0.00	0.00	0.23	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.14	9.47	1.89	1.26	12.41	0.00	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	16.31	2.45	0.82	0.00	2.65	0.00	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.16	4.51	0.43	0.43	2.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.56	11.34	0.89	0.67	7.34	0.00	0.22	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	13.36	3.72	1.10	0.22	5.04	0.00	0.00	0.00	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	6.08	0.00	0.00	8.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.58	2.45	0.82	0.54	3.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.94	11.76	1.47	2.35	11.76	0.00	0.29	0.00	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	2.18	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.34	4.81	0.48	0.00	2.40	0.00	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.61	11.21	2.40	4.00	11.21	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	0.00	1.37	0.00	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.52	3.50	1.00	1.00	4.00	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	6.12	0.00	0.00	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.77	2.63	0.88	0.88	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	15.45	2.21	2.21	5.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	30.10	2.56	0.64	0.00	2.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.81	4.96	0.74	0.99	1.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	19.49	13.22	1.39	0.70	6.26	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	0.00	0.00	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	34.53	2.39	0.34	0.00	2.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	10.94	1.31	1.75	10.94	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.47	1.07	0.36	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.70	3.09	0.28	0.28	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.78	14.55	2.91	2.49	12.88	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.89	1.17	0.58	0.00	0.58	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	31.98	4.52	0.60	0.00	2.71	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	24.21	13.36	1.25	0.83	12.94	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	1.85	0.00	0.00	1.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.92	18.78	5.12	2.85	10.81	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.96	1.38	0.14	0.28	1.52	0.00	0.14	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	27.73	1.04	0.26	0.00	2.59	0.00	0.00	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.16	9.87	2.14	1.29	8.58	0.00	0.43	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.14	1.91	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.70	3.74	0.27	0.27	1.87	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	34.42	14.07	3.89	4.19	12.57	0.00	0.00	0.00	0.00	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.85	0.85	0.00	0.14	0.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.93	0.96	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.99	16.81	2.21	1.77	11.72	0.00	0.00	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.85	0.76	0.38	0.38	1.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	26.71	1.14	0.28	0.57	1.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.63	15.24	3.20	0.49	13.52	0.00	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	30.63	0.65	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	30.87	0.59	0.00	0.59	1.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.00	10.38	1.73	1.73	12.69	0.00	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	37.51	1.24	0.00	0.41	1.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.50	1.19	0.30	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	3.56	0.00	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	18.07	9.53	0.33	0.66	9.53	0.00	0.00	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	7.36	0.00	0.00	5.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.21	17.99	1.19	0.59	14.43	0.00	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	2.79	0.00	0.00	7.45	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.27	19.90	1.50	0.75	16.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.52	9.59	0.80	0.00	10.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.63	4.52	0.23	0.23	3.39	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	3.68	0.74	0.00	2.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.92	10.26	1.83	0.00	8.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	7.78	0.00	0.00	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.88	3.74	0.00	0.00	3.74	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	13.13	5.05	1.01	12.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	8.01	1.26	1.26	7.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	5.45	1.36	0.00	4.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	2.43	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	9.06	0.00	0.00	6.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	22.84	5.71	0.00	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	0.00	0.00	0.00	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	47.83	5.82	3.23	3.23	3.02	0.00	0.65	0.00	0.00	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	44.94	2.61	3.14	1.57	2.61	0.00	0.00	0.52	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.05	12.01	0.67	1.33	4.67	0.00	0.67	0.67	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	46.33	29.22	7.51	10.85	11.27	0.00	0.83	0.00	0.00	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	41.64	17.30	9.51	12.74	4.37	0.00	3.99	2.66	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	25.53	11.17	11.17	6.38	0.00	3.19	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	47.60	23.12	3.40	3.40	7.48	0.00	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	18.38	7.35	1.84	11.03	3.68	1.84	0.00	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	53.99	21.76	3.77	5.02	5.86	0.00	1.26	1.67	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	51.83	36.26	11.62	10.23	10.69	0.00	0.93	1.16	0.23	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	75.12	37.83	9.19	6.76	13.78	0.00	2.97	3.51	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	64.54	26.07	13.67	10.93	9.04	0.00	2.10	3.15	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	11.13	0.00	11.13	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	50.13	23.33	5.96	5.96	7.94	0.00	1.99	1.49	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	83.37	14.07	0.81	2.98	6.23	0.00	0.81	4.87	0.81	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	84.55	49.87	13.60	13.60	12.01	0.00	2.49	2.04	0.91	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	79.85	28.09	8.17	8.82	13.55	0.16	1.63	2.29	0.49	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	84.57	30.62	9.84	7.29	10.75	0.00	1.09	2.37	0.73	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	108.21	30.77	5.83	3.18	7.96	0.00	1.06	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	82.84	34.82	6.60	4.80	11.41	0.00	1.80	1.20	0.60	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	72.20	9.19	2.63	2.30	4.92	0.00	1.97	4.59	0.98	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	106.19	35.78	9.11	8.13	14.31	0.00	2.44	0.81	0.00	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	72.49	25.40	5.64	5.12	10.76	0.00	1.06	2.65	0.35	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	95.64	28.13	2.11	2.81	17.58	0.00	2.11	0.00	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	94.24	32.64	4.60	6.44	16.55	0.00	2.76	3.68	0.92	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	102.19	23.78	3.86	2.57	17.03	0.00	1.61	1.61	1.29	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	79.67	20.00	5.17	6.21	6.21	1.03	1.38	3.10	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	55.63	7.59	0.00	2.53	0.00	0.00	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	73.96	21.61	5.57	4.46	10.69	0.00	1.11	2.23	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	85.10	30.06	2.96	1.27	13.13	0.00	2.54	3.39	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	80.94	23.74	7.36	5.22	12.82	0.00	2.14	3.32	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	110.32	17.60	6.01	1.72	12.45	0.00	1.72	1.29	0.43	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	18.06	9.03	18.06	9.03	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	106.63	27.66	4.00	4.00	11.33	0.00	1.33	1.67	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	62.22	18.03	3.61	1.80	7.21	0.00	1.80	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	50.79	21.43	2.38	1.59	10.32	0.00	3.17	1.19	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	111.44	45.50	9.29	9.29	23.22	0.00	0.93	3.71	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	87.40	18.54	3.41	1.89	12.49	0.00	1.51	5.30	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	67.13	22.49	5.54	2.61	13.04	0.00	0.00	0.00	0.33	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	77.13	25.71	3.05	3.49	17.43	0.00	2.61	3.49	0.87	2.18
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	59.25	10.85	2.26	3.17	7.24	0.00	0.90	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	59.09	29.10	2.65	5.29	13.23	0.00	5.29	1.76	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	117.68	51.86	7.31	6.65	31.91	0.00	4.65	1.99	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	121.53	26.79	3.97	1.98	17.86	0.00	1.49	4.96	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	58.57	19.14	6.51	3.45	9.57	0.00	0.77	0.00	0.77	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	178.44	26.01	7.26	6.65	23.29	0.00	3.63	8.77	2.12	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	54.81	5.97	3.09	3.76	3.76	0.00	0.66	1.77	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	69.80	25.75	3.39	2.71	13.55	0.00	0.00	2.03	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	10.22	0.00	0.00	5.11	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	116.45	28.05	4.27	1.22	23.17	0.00	2.44	3.66	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	57.60	12.27	3.15	5.67	15.11	0.00	0.94	2.20	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	84.44	34.50	9.38	6.05	32.08	0.00	2.42	1.51	0.91	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	83.86	11.08	1.58	2.37	8.70	0.00	1.58	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	58.95	9.07	0.00	2.27	3.40	0.00	0.00	4.53	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	0.00	5.06	5.06	0.00	0.00	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	53.67	11.93	3.85	4.35	3.48	0.37	1.61	0.62	0.25	0.25
Myoblast, donor2	11322-117D8	63.48	2.88	0.96	0.38	1.34	0.00	0.19	1.34	0.00	0.38
Myoblast, donor3	11398-118D3	82.90	18.16	9.25	8.07	4.54	2.02	1.85	1.18	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	10.51	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	39.05	10.76	6.46	4.00	5.54	0.00	1.23	1.23	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	23.22	11.76	12.97	11.76	2.71	0.00	2.11	1.81	2.11	0.00
Natural Killer Cells, donor3	11387-118C1	19.69	7.36	4.60	3.13	4.42	0.00	1.10	0.55	0.37	0.00
Neural stem cells, donor1	11275-116H6	78.39	8.35	5.81	5.81	5.44	4.36	3.63	1.09	2.54	0.36
Neural stem cells, donor2	11352-117H2	86.65	3.85	7.70	7.70	3.85	1.93	0.00	1.93	1.93	0.00
Neurons, donor1	11494-119E9	39.83	4.55	2.28	5.69	2.28	1.14	5.69	0.00	0.00	0.00
Neurons, donor2	11574-120E8	41.61	1.76	3.30	1.98	0.44	0.66	1.10	1.54	0.66	0.00
Neurons, donor3	11655-122E8	36.18	5.76	5.76	2.47	4.11	0.82	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	20.77	0.61	0.61	0.00	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	114.94	4.39	1.78	2.02	1.66	0.00	0.24	1.42	0.83	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	42.00	5.54	3.58	3.58	1.95	0.00	0.00	1.30	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	53.95	5.01	1.60	2.21	0.80	0.20	0.60	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	63.73	2.34	1.24	1.65	2.34	0.00	0.55	0.41	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	44.44	7.53	1.59	1.59	2.03	0.00	0.87	1.59	0.00	0.43
Olfactory epithelial cells, donor3	11935-125I9	43.25	5.33	1.93	2.38	2.61	0.00	0.23	1.02	0.57	0.23
Olfactory epithelial cells, donor4	11936-126A1	117.36	3.02	1.27	1.46	1.66	0.00	0.39	0.39	0.00	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	56.57	1.20	0.60	0.00	0.60	0.00	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	65.08	5.32	0.64	1.70	2.98	0.21	0.21	0.64	1.06	0.21
Osteoblast - differentiated, donor2	11353-117H3	25.15	5.72	0.00	2.29	0.00	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	32.28	3.72	1.24	0.00	4.97	0.62	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	14.66	2.15	0.78	1.37	0.78	0.00	0.98	0.59	0.20	0.00
Osteoblast, donor2	11354-117H4	45.65	3.51	6.32	7.73	3.51	0.00	0.70	2.11	0.00	0.70
Osteoblast, donor3	11426-118G4	51.72	5.15	4.80	3.55	1.24	0.18	0.36	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	90.22	54.58	31.67	26.28	17.86	0.08	3.71	3.20	2.70	1.01
Pericytes, donor1	11491-119E6	10.13	0.56	0.22	0.00	0.22	0.11	0.00	0.11	0.45	0.11
Pericytes, donor2	11571-120E5	9.51	2.49	0.45	0.45	0.23	0.00	0.00	0.45	0.68	0.23
Pericytes, donor3	11652-122E5	41.10	0.20	0.41	0.41	0.00	0.20	0.00	1.02	0.00	0.00
Perineurial Cells, donor1	11499-119F5	83.75	1.81	1.58	3.84	0.11	0.11	0.45	1.36	0.79	0.11
Perineurial Cells, donor2	11579-120F4	25.12	10.21	4.14	2.94	3.04	0.00	0.09	0.55	0.18	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	32.19	1.91	0.96	1.27	1.27	0.00	0.32	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.49	4.90	1.47	2.45	1.22	0.00	0.24	0.73	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.69	1.94	0.39	0.52	0.52	0.00	0.39	0.52	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	26.55	0.00	1.67	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	41.03	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	33.77	0.59	0.20	1.18	0.59	0.00	0.00	0.20	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	64.87	36.71	14.24	12.66	14.24	0.00	1.90	1.58	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	57.03	51.77	13.69	14.63	14.44	0.00	1.50	2.25	0.75	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	63.83	42.16	19.32	14.62	13.05	0.00	2.74	3.00	0.00	0.78
Preadipocyte - breast, donor2	11328-117E5	46.16	38.95	14.86	12.38	13.96	0.00	1.58	2.03	0.23	0.90
Preadipocyte - omental, donor1	11468-119C1	108.90	47.63	13.75	12.25	12.47	0.00	2.56	3.73	0.32	0.75
Preadipocyte - omental, donor2	11329-117E6	78.56	55.87	22.26	20.51	14.40	0.00	2.18	1.75	1.31	1.75
Preadipocyte - omental, donor3	11403-118D8	104.28	24.07	11.60	6.88	9.60	0.00	1.72	1.86	0.14	0.86
Preadipocyte - perirenal, donor1	11469-119C2	86.62	21.65	10.83	0.98	5.91	0.00	0.00	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	13.51	7.06	2.76	0.61	2.15	0.00	0.00	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	16.47	9.92	3.90	4.43	2.48	0.00	1.06	1.24	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	34.23	13.96	6.81	4.94	5.28	0.00	0.85	1.87	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	37.72	10.34	5.59	4.47	3.91	0.28	1.12	1.49	0.75	0.19
Preadipocyte - visceral, donor2	11357-117H7	20.71	15.19	5.06	11.04	6.90	0.00	0.92	0.00	0.00	1.84
Preadipocyte - visceral, donor3	11429-118G7	24.14	40.86	9.20	9.61	7.73	0.10	1.46	0.84	0.10	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.68	0.60	0.60	0.60	0.60	0.00	0.15	0.15	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	75.29	0.41	0.14	0.00	0.41	0.00	0.00	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	23.39	0.18	0.55	0.18	0.06	0.00	0.12	0.37	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	56.27	3.76	1.82	1.37	1.59	0.00	0.68	1.03	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	41.24	4.84	2.15	2.87	1.97	0.00	0.54	0.90	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	64.23	6.15	1.88	2.19	1.77	0.00	0.42	0.83	0.42	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	23.72	0.00	0.36	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	93.50	0.49	0.42	0.35	0.07	0.14	0.28	0.28	0.00	0.00
Renal Epithelial Cells, donor1	11517-119H5	18.77	0.51	0.00	0.00	0.00	0.00	0.51	1.01	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	17.78	0.71	0.71	0.00	0.00	4.27	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	111.37	2.12	1.16	1.59	0.32	1.69	0.42	0.64	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.70	1.36	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.68	1.75	0.94	0.81	0.00	0.00	0.13	0.00	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	33.08	4.00	1.78	1.11	0.67	0.00	0.22	0.22	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.98	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	17.83	1.10	1.32	0.88	0.44	1.32	0.00	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	36.99	0.63	0.63	0.00	0.63	0.00	0.00	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.66	0.28	0.28	0.28	0.28	0.28	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	37.85	0.54	1.34	0.27	0.00	0.00	0.00	0.54	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.08	0.00	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.01	0.58	0.19	0.19	0.19	0.00	0.19	0.39	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	32.93	3.89	4.15	1.04	1.04	0.00	2.07	0.52	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.84	2.27	0.85	1.14	1.42	0.00	0.28	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	1.03	0.00	0.00	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	43.16	2.01	0.50	0.50	1.25	0.00	0.50	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	96.49	3.07	1.20	0.80	0.94	0.00	0.00	0.27	0.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	6.25	0.89	0.89	0.89	0.00	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	34.67	1.65	0.00	0.00	0.00	0.00	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	29.00	3.48	0.00	0.00	1.16	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	42.39	3.51	0.78	0.13	0.52	0.00	0.13	0.26	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	33.96	3.57	0.20	0.10	0.50	0.00	0.20	0.10	0.10	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	41.72	3.01	0.56	0.56	1.00	0.00	0.11	0.56	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	38.08	1.86	0.25	0.00	0.25	0.00	0.37	0.62	0.50	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	32.98	3.38	0.00	0.35	1.05	0.00	0.12	0.58	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	31.67	2.31	0.46	0.46	0.46	0.00	0.00	0.92	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.14	2.60	0.55	0.14	0.82	0.00	0.14	0.00	0.14	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	30.56	2.12	0.30	0.30	0.45	0.00	0.00	0.15	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	45.34	2.87	0.54	0.00	0.54	0.00	0.18	0.36	0.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	32.71	4.30	0.43	0.00	0.72	0.00	0.29	0.43	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	31.34	2.79	0.21	0.00	0.75	0.00	0.00	0.21	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.09	4.20	0.22	0.44	1.33	0.00	0.00	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.72	3.82	0.76	0.38	0.57	0.00	0.00	0.57	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	32.14	2.79	0.37	0.19	0.28	0.00	0.19	0.09	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	45.47	3.95	0.00	0.00	1.50	0.00	0.19	0.38	0.38	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	36.89	4.51	0.40	0.40	1.06	0.00	0.13	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	33.10	3.11	0.19	0.10	0.88	0.00	0.19	0.58	0.10	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.27	3.63	0.38	0.38	0.38	0.00	0.19	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.59	3.52	0.21	0.32	0.75	0.00	0.00	0.11	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	29.15	2.80	0.00	0.00	0.28	0.00	0.00	0.00	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.25	3.59	0.68	0.17	1.03	0.00	0.17	0.34	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.27	3.10	0.18	0.18	0.36	0.00	0.00	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.04	3.80	0.61	0.00	0.25	0.00	0.12	0.12	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	36.94	2.69	0.13	0.27	0.27	0.00	0.00	0.27	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.48	2.59	0.47	0.24	0.47	0.00	0.00	0.00	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	30.75	3.17	0.79	0.20	0.40	0.00	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.14	1.64	0.00	0.47	0.70	0.00	0.00	0.00	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.58	3.73	0.21	0.21	0.62	0.00	0.21	0.41	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.99	3.32	0.44	0.22	0.66	0.00	0.00	0.00	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.95	3.34	0.00	0.00	0.42	0.00	0.00	0.21	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.07	4.04	0.40	0.27	1.08	0.00	0.00	0.54	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	29.46	2.90	1.02	0.00	0.85	0.00	0.00	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	34.32	2.51	0.77	0.39	0.77	0.00	0.19	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	34.73	3.78	0.17	0.00	0.34	0.00	0.17	0.52	0.17	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	32.37	2.47	0.41	0.14	1.10	0.00	0.00	0.55	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.88	4.43	0.16	0.16	0.82	0.00	0.16	0.00	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	30.85	4.09	0.00	0.00	0.68	0.00	0.00	0.34	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.22	3.11	0.00	0.15	0.30	0.00	0.15	0.44	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.99	5.06	0.27	0.00	0.53	0.00	0.00	0.00	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	37.06	4.29	0.28	0.14	1.11	0.00	0.14	0.28	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.62	2.38	0.24	0.00	0.95	0.00	0.00	0.24	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	44.74	4.84	0.20	0.00	0.60	0.00	0.00	0.40	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	38.14	3.48	0.57	0.09	0.85	0.09	0.09	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.74	4.19	0.00	0.35	1.40	0.00	0.00	0.35	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.57	4.53	0.91	0.30	1.21	0.00	0.00	0.30	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	44.30	3.06	0.37	0.12	0.37	0.00	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	63.61	5.09	0.58	0.29	1.16	0.00	0.29	0.00	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	41.98	6.08	0.61	0.00	0.61	0.00	0.00	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	45.21	3.32	0.60	0.30	0.00	0.00	0.00	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.58	6.11	0.23	0.00	0.90	0.00	0.00	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.33	4.49	0.60	0.30	1.80	0.00	0.30	0.30	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	45.46	5.90	0.71	0.12	1.06	0.00	0.12	0.59	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	53.57	4.70	0.00	0.43	1.92	0.00	0.00	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	54.69	1.80	0.00	0.60	2.40	0.00	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	10.72	2.44	2.26	1.13	0.00	0.00	0.56	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	27.22	10.21	3.40	0.00	0.00	0.00	0.00	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.57	7.01	3.94	2.63	0.66	0.66	1.53	2.41	0.22	0.22
Sebocyte, donor1	11220-116B5	52.04	0.55	0.55	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	25.74	0.92	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	26.79	0.62	0.21	0.62	0.21	0.00	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	235.24	21.54	4.97	1.66	4.97	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	141.22	22.59	2.82	16.95	5.65	0.00	0.00	0.00	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	38.01	9.50	10.56	9.41	2.73	0.09	1.23	1.58	0.35	0.44
Skeletal Muscle Cells, donor2	11358-117H8	7.23	2.17	0.72	0.72	0.72	0.00	2.89	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	35.95	5.85	4.18	4.18	1.67	1.67	2.51	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	32.68	6.13	1.89	2.83	1.10	0.47	1.10	1.10	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	27.50	4.46	2.08	3.42	0.59	0.00	0.30	1.49	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	24.93	4.62	2.46	1.85	0.77	0.15	0.46	1.08	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.60	4.54	1.64	1.76	0.76	0.00	0.25	3.78	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.67	3.71	2.43	3.28	1.57	0.00	0.57	1.43	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.89	3.47	1.59	0.99	0.69	0.10	0.79	1.59	0.20	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.10	2.19	1.77	2.70	1.10	0.08	0.93	1.52	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	23.88	11.58	13.03	12.30	2.90	0.00	2.90	2.17	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	29.72	12.38	8.12	6.60	3.30	0.00	1.10	1.10	0.55	1.10
Skin - palm, donor1	10286-104F7	48.35	16.12	5.37	5.37	10.74	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.68	0.00	0.14	0.00	0.00	0.00	0.00	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	229.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.47	0.13	0.00	0.00	0.00	0.00	0.39	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	29.19	0.28	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	28.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	130.67	0.21	0.00	0.00	0.00	0.00	0.00	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	35.30	0.15	0.07	0.15	0.00	0.00	0.00	0.07	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	60.79	5.55	1.23	0.00	0.93	0.00	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	250.57	98.49	22.90	16.90	13.78	0.00	2.22	0.22	0.00	1.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	69.95	17.05	7.64	3.53	3.53	0.00	0.00	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	36.46	6.19	1.55	1.77	1.99	0.00	0.44	0.44	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	25.20	11.03	9.45	5.51	0.79	0.00	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	51.76	17.00	9.27	3.09	4.64	0.00	0.00	0.77	0.00	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	13.01	1.00	0.00	2.00	0.00	0.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	55.49	15.17	4.39	2.00	2.79	0.00	1.60	0.53	0.00	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	52.98	25.49	2.44	1.55	5.98	0.00	0.44	0.66	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	45.58	16.39	4.23	2.82	3.46	0.00	0.13	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	41.68	6.84	3.91	2.28	0.65	0.00	0.65	2.60	1.63	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	54.04	4.13	3.25	1.77	1.77	0.00	0.59	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	52.11	2.70	0.57	0.85	1.28	0.14	0.28	1.14	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	9.11	0.33	0.33	0.33	0.00	0.00	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	30.44	4.57	2.44	1.22	1.83	0.00	0.00	0.61	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.72	29.55	9.34	3.03	6.57	0.00	1.01	0.76	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	42.84	12.24	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	30.52	3.34	0.48	1.91	1.91	0.00	0.00	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	72.26	3.54	2.21	0.74	1.33	0.15	0.29	1.33	0.59	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	39.17	4.74	1.72	0.86	1.08	0.43	0.43	1.29	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	53.74	4.62	1.26	2.10	1.36	0.42	0.52	1.15	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	30.32	15.00	8.51	5.10	1.55	0.00	0.77	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	24.79	11.86	2.16	3.23	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	31.08	12.25	1.49	0.60	2.39	0.00	0.60	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.92	0.34	0.00	0.34	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	76.25	0.86	0.31	0.39	0.08	0.00	0.16	0.86	0.31	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	156.09	64.11	20.03	20.63	12.08	0.00	2.11	1.41	0.20	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	48.01	57.80	11.38	5.69	9.78	0.00	1.82	0.23	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.19	10.26	0.60	1.21	0.60	0.00	0.60	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	44.51	5.30	2.12	1.06	0.79	0.26	0.26	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	94.41	6.66	5.19	3.06	2.13	0.00	0.13	0.67	0.27	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	56.47	9.27	3.13	2.25	2.25	0.00	1.00	1.00	0.13	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	47.43	8.62	3.80	4.82	2.54	0.00	0.76	2.54	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.75	89.41	22.77	13.27	15.53	0.00	2.11	1.06	0.75	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	34.51	48.01	24.76	15.75	7.50	0.00	0.75	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	2.58	0.00	2.58	1.29	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	56.74	70.69	22.32	13.95	12.09	0.00	1.86	0.47	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.84	42.91	13.63	8.58	9.59	0.00	0.50	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	47.95	63.31	14.73	6.27	10.03	0.00	2.19	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	0.29	0.88	0.00	0.29	0.00	0.00	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	28.24	4.83	1.92	1.33	1.25	1.50	0.67	0.75	0.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	49.99	9.34	3.27	0.47	3.74	0.47	0.00	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	58.57	6.33	2.88	2.30	1.87	0.00	0.14	0.14	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.48	4.33	2.55	1.02	2.04	0.00	0.51	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.20	6.96	1.88	1.88	1.32	0.00	0.94	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.08	7.27	6.71	7.97	0.98	3.07	0.98	1.68	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	53.46	1.26	1.51	0.50	0.50	2.01	0.00	0.42	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.48	0.48	0.00	0.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	59.21	3.67	1.22	1.22	1.22	0.00	0.00	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	69.38	9.28	6.63	5.52	1.33	0.00	0.22	1.33	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.48	12.87	11.12	7.90	3.51	0.29	0.59	1.17	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	94.85	7.97	1.55	0.19	5.25	0.00	0.39	3.11	1.75	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	105.78	16.40	5.29	5.29	4.50	0.00	0.26	0.26	0.00	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	117.91	4.09	2.23	0.74	1.49	0.00	0.37	2.23	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	158.47	8.98	3.23	1.80	4.67	0.00	0.72	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	92.55	23.28	5.11	4.83	6.81	0.00	1.70	0.28	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.24	9.45	5.51	3.15	3.15	0.00	1.18	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	92.95	13.71	5.08	3.81	5.08	0.00	0.51	1.27	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	219.23	15.57	3.59	7.59	6.39	0.00	0.80	1.20	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	94.05	9.20	3.34	3.34	5.43	0.00	1.67	1.25	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	88.01	21.54	5.50	2.29	8.25	0.00	0.92	1.38	0.00	0.92
Synoviocyte, donor1	11291-117A4	124.56	14.31	4.04	1.51	3.53	0.00	1.01	0.34	0.17	0.17
Synoviocyte, donor2	11368-117I9	99.23	71.41	23.47	12.74	21.29	0.00	2.85	2.68	0.67	0.84
Synoviocyte, donor3	11440-118H9	62.55	44.91	18.99	9.38	10.50	0.00	2.01	2.46	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	12.15	4.29	4.29	1.79	1.07	1.07	2.86	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.96	5.09	2.78	2.78	0.69	0.00	0.93	1.85	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	19.57	0.07	0.00	0.00	0.00	0.00	0.00	0.07	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	16.62	1.16	0.00	0.39	0.77	0.00	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	101.86	2.21	1.72	0.98	1.48	0.00	0.25	0.62	0.25	0.12
Urethra, donor2	10319-105A4	50.36	21.58	1.80	0.00	3.60	0.00	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	23.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	15.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	15.36	0.00	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	42.80	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	36.48	0.89	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	32.88	1.43	1.43	0.00	1.43	0.00	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.17	0.68	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	26.86	0.34	0.34	0.34	0.69	0.00	0.34	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	28.47	1.74	0.00	0.00	0.00	0.00	0.58	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	34.36	3.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	32.12	1.84	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	18.48	0.00	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.36	0.28	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	28.93	10.33	2.07	4.13	4.13	0.00	0.00	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	22.52	0.23	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	12.23	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.34	1.69	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.85	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.34	25.86	4.08	1.09	6.26	0.00	1.91	0.00	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	15.86	0.44	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	26.14	0.82	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	20.19	2.72	1.16	0.78	0.78	0.00	0.39	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.54	0.18	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	24.63	49.96	3.49	0.93	5.58	0.00	1.39	0.46	3.25	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.44	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	33.31	1.23	0.41	0.00	0.82	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	30.08	1.23	0.00	0.00	0.61	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.59	1.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.71	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	21.90	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	8.34	2.67	1.67	0.00	0.67	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	5.65	30.89	2.26	0.38	3.01	0.00	1.13	0.38	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	19.63	13.52	1.31	0.00	4.80	0.00	0.00	0.44	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	5.62	0.00	3.75	1.87	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	15.54	2.35	0.00	0.24	0.71	0.00	0.00	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	77.56	9.15	5.27	5.12	6.52	0.00	1.40	2.64	2.48	0.00
adipose, donor1	10184-103D4	44.57	11.73	17.59	18.77	4.10	6.45	4.69	12.31	34.60	1.17
adipose, donor2	10185-103D5	71.37	8.11	3.65	6.89	3.65	13.38	3.24	2.43	3.24	0.00
adipose, donor3	10186-103D6	53.10	5.99	6.26	3.81	1.91	7.90	1.09	3.81	3.27	0.27
adipose, donor4	10187-103D7	31.20	4.33	4.33	0.87	1.73	0.00	0.87	9.53	6.07	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	34.88	7.42	1.58	1.74	1.89	0.00	0.47	0.79	0.16	0.95
adrenal gland, adult, pool1	10081-102A9	58.20	32.74	36.38	40.01	7.28	10.91	3.64	7.28	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	15.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	47.16	17.51	11.43	8.58	3.22	0.00	3.22	1.43	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	201.25	0.00	0.23	0.00	0.00	0.00	0.00	0.46	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	113.26	1.35	0.68	0.34	1.01	0.00	0.34	2.37	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	149.07	0.29	0.29	0.00	0.00	0.00	0.29	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	79.45	5.93	4.74	5.93	5.93	30.83	1.19	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	39.13	2.64	1.42	1.82	1.82	4.26	0.41	2.03	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	51.00	4.52	3.55	2.90	2.26	20.33	0.32	1.61	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	77.16	1.27	1.15	0.25	0.51	0.00	0.13	0.00	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	85.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.75	0.67	0.00	0.00	0.00	0.00	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	259.68	33.93	16.87	7.45	19.02	0.00	2.94	5.10	1.96	0.39
appendix, adult	10189-103D9	48.13	7.76	1.16	0.00	3.49	1.16	0.39	0.39	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	98.37	0.69	0.00	0.34	0.34	132.42	0.00	0.00	0.00	0.34
artery, adult	10190-103E1	76.09	6.79	4.08	4.08	6.79	0.00	4.08	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	97.79	21.59	22.02	8.40	8.11	0.14	2.46	0.72	0.72	0.14
b cell line:RPMI1788	10427-106D4	58.14	0.15	0.15	0.59	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	135.39	26.91	9.99	8.60	9.16	0.00	2.22	1.66	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.17	3.77	4.37	2.48	0.60	0.00	0.40	0.60	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	10.54	0.00	0.17	0.00	0.17	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	72.46	11.62	3.48	3.48	9.34	0.00	0.65	3.37	2.61	0.43
blood, adult, pool1	10053-101G8	11.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	71.08	16.27	5.14	6.85	3.43	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	41.84	3.37	0.00	2.02	2.02	0.00	0.00	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	38.95	9.23	4.10	2.05	6.15	1.03	0.00	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	63.14	4.68	1.67	1.11	2.45	0.89	0.11	1.56	0.56	0.11
brain, fetal, pool1	10085-102B4	40.07	0.00	0.00	2.67	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	17.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	10.36	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	72.61	9.47	0.63	1.26	8.84	0.00	1.26	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.11	3.56	2.03	0.25	1.27	0.00	0.00	0.13	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	59.37	0.93	0.00	0.31	0.00	0.00	0.31	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	23.02	0.92	0.23	0.00	0.23	0.00	0.00	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	18.64	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	25.39	1.88	1.41	0.47	0.47	0.47	0.47	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.22	2.41	3.50	1.97	0.33	105.33	0.98	0.55	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	78.27	0.00	0.00	0.63	0.00	1.58	0.32	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	72.13	18.37	9.58	6.39	6.92	2.93	1.06	2.13	4.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	117.43	9.21	11.51	2.30	2.30	1.15	1.15	2.30	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	101.90	2.84	4.69	5.52	1.51	2.01	2.84	4.02	0.67	0.00
caudate nucleus, adult, donor10258	10379-105H1	291.90	9.17	3.82	17.58	1.53	4.58	1.53	3.06	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	78.37	3.30	5.49	5.86	2.20	26.00	0.37	2.20	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	67.01	2.91	0.00	2.91	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	62.56	2.14	0.00	0.21	0.85	0.00	0.00	0.21	0.43	0.00
cerebellum, adult, pool1	10083-102B2	42.08	3.79	0.00	0.69	2.07	0.00	0.00	0.00	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	42.34	3.32	0.83	0.00	3.32	0.00	0.00	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	75.14	10.59	2.77	7.06	4.03	7.31	1.51	2.27	1.76	0.76
cerebrospinal fluid, donor2	10294-104G6	27.77	9.50	7.31	4.39	6.58	0.00	2.19	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	28.47	0.00	0.29	0.14	0.14	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	30.49	0.99	0.66	1.16	0.00	0.00	0.33	0.83	0.00	0.00
cervix, adult, pool1	10013-101C4	158.33	43.36	15.33	10.50	22.47	0.00	4.72	7.35	15.75	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	119.27	11.01	7.11	1.25	4.04	0.00	1.11	0.70	0.00	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	58.78	3.92	6.53	1.31	0.00	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	73.70	0.25	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.12
choriocarcinoma cell line:SCH	10785-110H2	18.36	0.25	0.00	0.12	0.12	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	11.15	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	219.67	3.13	1.99	1.71	0.57	0.00	0.57	0.85	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	104.40	7.56	4.37	4.57	2.39	0.00	0.99	2.29	0.30	0.30
chorionic membrane cells, donor3	12240-129G8	175.29	1.10	1.65	0.55	0.00	0.00	0.00	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.32	0.96	0.58	0.38	0.38	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	16.05	2.75	0.42	0.21	1.06	0.00	0.00	0.00	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	21.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	30.23	6.78	1.82	0.00	1.56	0.00	0.00	0.00	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	45.72	1.37	0.69	0.23	0.00	0.00	0.00	0.00	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	57.43	4.51	2.26	2.08	1.74	0.00	0.35	1.21	1.04	0.35
colon carcinoma cell line:CACO-2	10513-107D9	18.85	0.18	0.18	0.00	0.00	0.00	0.00	0.00	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	74.50	5.70	4.18	1.14	0.76	11.40	0.00	1.52	0.38	0.38
colon, adult, donor1	10082-102B1	49.98	20.23	0.00	0.00	5.95	2.38	0.00	3.57	3.57	0.00
colon, adult, pool1	10014-101C5	89.42	8.23	2.00	0.82	4.82	3.41	0.24	0.71	0.94	0.35
colon, fetal, donor1	10070-101I7	80.96	14.21	0.62	1.24	6.18	3.09	0.00	1.24	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	105.42	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.14	6.37	2.12	0.42	11.90	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	22.79	0.60	0.15	0.15	1.51	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	21.01	1.27	0.14	0.00	1.41	0.00	0.00	0.00	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	40.69	3.43	1.77	2.32	3.10	0.77	0.55	1.33	1.11	0.33
cruciate ligament, donor2	10295-104G7	59.16	22.69	6.48	5.67	25.94	0.00	4.05	3.24	4.05	0.00
diaphragm, fetal, donor1	10069-101I6	42.54	36.92	5.62	3.21	12.04	0.00	0.80	1.61	5.62	1.61
diencephalon, adult	10193-103E4	60.48	3.84	3.36	2.88	3.84	0.96	1.44	0.96	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.39	1.28	0.00	0.00	0.00	0.00	0.26	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	30.57	0.00	0.72	0.72	0.00	0.00	0.48	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	42.36	13.46	1.99	1.99	4.49	0.00	1.50	1.99	4.49	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	60.49	20.16	2.88	1.44	8.64	5.76	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	59.59	13.24	0.74	1.47	8.09	8.83	0.74	2.21	3.68	0.00
dura mater, adult, donor1	10041-101F5	117.44	4.54	4.46	3.63	1.90	0.41	0.74	2.56	2.31	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.10	2.22	3.11	0.89	0.22	1.33	0.44	0.89	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.20	6.30	6.02	4.87	1.86	0.00	1.86	1.72	0.72	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	22.20	2.47	3.70	0.62	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	24.82	1.82	1.21	0.30	0.30	0.00	0.00	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	22.23	2.78	1.54	0.62	0.00	0.00	0.00	0.31	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	13.13	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	50.95	0.67	0.34	0.00	0.34	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	8.70	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.79	0.16	0.00	0.00	0.00	0.00	0.00	0.16	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	26.57	0.11	0.11	0.00	0.00	0.00	0.11	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	42.12	0.22	0.55	0.33	0.00	0.00	0.00	0.22	0.00	0.00
epididymis, adult	10197-103E8	65.10	54.63	6.28	3.35	44.16	0.00	2.51	5.65	8.58	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.90	3.73	4.08	3.90	0.00	0.00	0.35	1.24	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	19.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.80	1.70	0.79	0.52	0.79	0.00	0.13	0.39	0.00	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	19.78	1.87	0.59	0.89	0.10	0.00	0.20	0.20	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	22.18	1.34	0.78	0.22	0.22	0.00	0.22	0.11	0.00	0.11
esophagus, adult, pool1	10015-101C6	55.74	8.71	1.49	1.27	6.26	0.00	0.74	1.49	1.49	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	43.46	4.83	2.41	4.83	4.83	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	37.88	10.52	4.21	0.00	4.21	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	23.81	22.32	10.42	10.42	14.88	0.00	1.49	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	41.27	17.20	4.59	4.59	8.03	0.00	1.15	1.15	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	8.74	0.00	0.00	4.37	0.00	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	63.05	11.95	4.58	4.58	11.95	0.25	0.51	2.29	5.08	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	58.21	4.49	3.08	3.59	1.67	0.13	0.64	0.77	0.00	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.30	5.94	4.04	2.85	1.90	0.00	0.00	0.71	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	88.66	5.63	3.85	3.75	3.28	6.85	0.56	1.41	0.94	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	87.50	2.29	1.65	0.64	0.37	0.00	0.27	1.83	0.18	0.09
gall bladder, adult	10198-103E9	60.60	8.69	0.97	0.97	8.21	0.00	0.24	1.21	3.38	0.00
gamma delta positive T cells, donor1	11937-126A2	44.56	9.66	2.15	2.15	2.15	0.00	0.00	1.07	2.68	0.00
gamma delta positive T cells, donor2	11938-126A3	26.89	17.55	5.60	6.35	5.98	0.00	0.75	2.24	2.24	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.81	8.45	4.86	1.06	2.53	0.00	1.06	2.53	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.82	0.19	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	20.66	25.90	14.76	7.54	8.36	0.33	0.98	1.31	0.98	0.49
gastric cancer cell line:GSS	10560-108A2	41.19	10.07	1.83	0.92	2.75	0.00	0.00	0.00	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	34.73	13.94	11.65	14.39	6.17	65.80	1.83	1.14	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	23.18	0.80	4.36	4.47	0.00	0.00	0.34	0.46	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	51.92	0.84	0.56	0.42	0.14	0.00	0.42	0.56	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	57.84	7.81	5.28	7.71	2.96	0.11	2.11	1.79	0.63	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	53.37	7.16	7.72	7.58	3.23	0.00	2.39	1.12	0.14	0.42
glioblastoma cell line:T98G	10485-107A8	36.09	1.43	0.22	0.00	0.66	0.00	0.00	0.33	0.22	0.22
glioma cell line:GI-1	10413-106B8	29.87	4.98	7.32	4.39	2.93	0.29	0.00	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	67.06	6.56	9.48	3.64	4.37	2.19	0.00	2.92	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	32.95	1.71	0.24	0.98	1.22	0.00	0.24	0.49	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	30.12	2.74	1.37	1.37	0.00	1.37	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	51.69	4.26	3.73	3.20	1.60	0.53	1.07	1.60	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	112.57	14.68	2.45	9.79	7.34	0.00	0.00	12.24	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	49.28	6.72	4.48	3.20	1.28	0.00	0.96	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	18.36	1.84	0.92	1.38	0.46	0.00	0.46	0.92	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.92	0.46	0.46	0.91	0.00	0.00	0.91	0.00	3.66	0.00
hIPS +CCl2, biol_rep3	14385-156C2	22.54	1.29	1.93	1.93	0.00	0.00	0.00	3.22	0.64	0.00
hIPS, biol_rep1	14380-156B6	7.19	1.44	0.00	1.44	0.00	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	12.35	0.69	0.69	0.69	0.69	0.00	0.69	2.74	3.43	0.00
hIPS, biol_rep3	14382-156B8	84.97	18.76	6.62	9.93	6.62	3.31	0.00	5.52	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.93	0.29	0.00	0.00	0.57	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	150.38	363.84	350.39	152.77	80.72	0.00	41.86	6.58	12.56	1.49
heart - pulmonic valve, adult	10206-103F8	124.20	54.91	104.59	58.05	20.40	0.00	13.34	4.18	1.83	0.26
heart - tricuspid valve, adult	10207-103F9	114.90	19.15	47.46	28.31	10.82	0.00	5.00	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	72.44	96.72	81.01	13.88	32.65	0.00	9.59	0.61	0.00	1.02
heart, adult, diseased, donor1	10051-101G6	120.08	262.31	175.44	43.01	76.22	0.00	22.99	2.13	0.00	1.70
heart, adult, pool1	10016-101C7	146.27	127.87	331.40	110.39	53.81	0.00	27.14	2.53	1.38	0.92
heart, fetal, pool1	10046-101G1	204.54	201.05	662.59	228.05	33.99	0.31	39.53	4.72	19.92	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	186.35	15.43	3.70	5.86	3.09	0.00	0.62	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	16.13	1.22	0.22	0.00	0.55	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	15.78	0.97	0.00	0.00	0.49	0.00	0.00	0.24	0.00	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	18.29	1.21	0.30	0.00	0.61	0.00	0.00	0.10	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	16.90	0.67	0.11	0.00	0.11	0.00	0.00	0.11	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	10.15	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	42.58	5.68	1.89	0.95	4.73	0.00	0.00	1.89	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	36.74	3.88	1.02	0.82	1.22	0.82	0.20	0.82	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	60.25	7.47	3.98	2.49	5.48	4.48	1.00	0.00	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	58.86	2.11	3.88	4.23	1.76	1.06	2.11	3.88	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	31.74	1.22	0.61	1.83	0.61	1.83	0.00	1.22	3.05	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.40	1.18	0.59	1.18	0.20	0.59	0.39	0.98	0.79	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.72	1.02	0.76	2.29	0.25	0.25	0.25	1.02	1.27	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.83	9.59	9.02	15.22	2.82	0.56	2.82	4.51	11.84	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.28	10.84	6.20	10.07	2.58	0.26	0.52	3.87	9.04	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.62	7.97	5.69	9.11	0.76	0.76	0.76	4.93	10.63	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	46.71	5.55	3.80	4.09	2.04	4.96	2.04	2.34	1.75	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	46.32	4.74	2.59	3.02	1.29	3.66	0.43	1.29	1.72	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.37	7.09	5.00	6.67	2.09	5.00	1.25	2.92	2.09	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	45.46	4.97	8.05	5.45	1.89	5.21	1.66	0.71	2.84	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.86	5.79	4.66	5.63	2.09	2.89	0.64	1.93	1.93	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.07	12.79	17.51	8.08	2.69	7.41	1.35	1.35	4.71	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.51	0.78	1.88	1.88	0.16	0.31	0.31	2.50	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	30.95	0.98	1.97	1.97	0.00	0.49	0.49	1.47	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	22.69	0.87	0.00	2.62	0.00	0.87	0.00	0.00	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	56.70	19.09	19.85	15.65	5.54	1.34	6.49	8.78	12.98	1.15
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	66.72	21.37	22.24	17.44	3.05	3.49	9.59	9.59	19.19	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	62.97	13.49	16.99	25.49	3.50	7.50	10.99	14.49	28.99	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	65.75	6.22	3.77	3.96	1.70	10.55	1.51	2.45	3.01	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	70.94	7.28	8.18	8.18	1.36	17.28	2.27	3.64	4.55	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	72.98	5.64	5.64	7.20	2.51	16.91	2.82	4.70	5.33	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	56.34	8.33	5.23	4.57	2.12	9.47	2.12	4.57	4.57	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	62.42	6.97	3.77	6.68	2.32	10.74	2.90	4.06	3.77	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	85.49	11.06	5.68	5.68	2.09	17.64	1.79	4.78	7.47	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.39	0.92	1.48	1.11	0.37	0.18	0.74	1.48	1.66	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.24	0.29	1.14	0.86	0.00	0.00	0.29	1.14	1.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.93	0.41	0.82	0.41	0.41	0.00	0.82	2.04	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.60	20.07	17.96	10.91	4.58	1.41	3.52	5.63	11.62	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.39	17.10	9.50	11.40	4.12	1.90	3.17	5.70	8.55	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	49.33	12.71	12.10	10.29	2.12	1.51	4.84	9.99	11.80	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	58.43	6.21	8.27	7.76	3.10	8.79	1.03	5.17	5.69	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	61.10	11.29	9.30	8.63	3.98	8.63	5.98	6.64	7.97	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	53.62	8.72	5.39	4.62	4.36	12.57	1.54	3.33	4.10	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	54.71	6.39	4.86	3.83	1.53	7.41	2.81	2.05	2.56	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	69.66	9.09	8.33	9.84	2.27	12.87	0.76	3.79	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	58.81	7.39	6.39	4.70	3.70	8.74	2.69	3.36	4.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.91	2.17	1.69	1.21	0.00	0.00	0.00	0.97	1.93	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.98	0.45	0.00	0.89	0.00	0.00	0.45	1.34	2.23	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.27	0.49	2.44	0.98	0.00	0.00	0.00	0.98	2.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	33.92	16.81	18.64	12.84	2.44	1.53	2.44	6.11	8.86	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	3.25	13.01	16.27	0.00	3.25	3.25	6.51	16.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	32.10	10.59	8.27	8.60	1.65	1.99	4.30	7.94	13.57	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	56.37	8.76	3.28	4.93	2.19	3.28	0.55	1.64	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	49.22	6.15	2.53	1.81	1.45	2.53	1.09	2.53	2.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	42.35	4.98	3.20	2.49	2.85	2.85	0.71	0.71	1.07	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	46.54	5.97	7.16	4.77	0.00	4.77	1.19	2.39	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	57.28	5.28	3.93	2.98	1.08	6.50	1.35	1.76	1.63	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	43.91	5.12	3.77	3.23	0.81	2.69	1.35	0.81	1.35	0.00
immature langerhans cells, donor1	11904-125F5	4.84	0.73	0.73	0.24	0.48	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	90.56	5.96	4.07	4.07	3.31	9.65	1.42	1.89	0.85	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	17.56	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	92.12	4.01	1.00	0.50	2.00	0.00	0.70	1.10	1.60	0.00
kidney, fetal, pool1	10045-101F9	84.25	10.68	1.70	1.06	3.89	0.00	0.35	1.63	4.60	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	100.83	1.42	0.57	0.14	0.43	0.14	0.00	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.99	0.14	0.00	0.14	0.00	0.00	0.14	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	36.52	1.65	1.10	1.28	0.92	0.00	0.18	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	183.61	484.92	812.92	508.35	117.14	0.00	93.71	5.99	11.44	3.81
left ventricle, adult, donor1	10078-102A6	90.01	122.87	195.18	59.67	40.96	0.00	15.68	1.52	0.51	2.02
leiomyoblastoma cell line:G-402	10721-110A1	46.24	3.56	0.82	1.09	0.82	0.00	0.00	0.55	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	54.61	61.79	24.43	16.88	11.50	0.36	5.03	2.51	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	53.80	18.48	5.98	3.26	4.35	0.00	0.54	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	38.61	122.14	40.31	20.15	22.82	0.00	6.07	2.67	0.97	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	44.45	6.35	6.35	25.40	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	40.78	5.23	2.09	1.05	2.09	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	30.22	0.83	0.71	0.24	0.24	0.00	0.12	0.12	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	94.66	10.15	5.31	2.03	3.44	0.00	1.41	2.81	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	69.69	12.79	8.53	3.53	6.09	0.00	1.46	2.80	1.34	1.46
liver, adult, pool1	10018-101C9	8.91	0.65	0.00	0.32	0.32	0.00	0.00	0.00	0.16	0.00
liver, fetal, pool1	10086-102B5	13.17	4.70	0.94	0.94	1.88	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	27.42	8.17	3.35	2.48	4.37	1.90	1.02	0.73	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	42.82	12.00	10.52	3.51	4.43	16.24	1.66	1.29	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	57.56	34.42	13.82	7.34	8.46	24.83	1.69	2.82	1.69	0.85
locus coeruleus, newborn, donor10223	10362-105F2	22.71	5.05	4.21	4.21	1.68	7.57	1.26	2.94	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	17.85	0.97	0.42	0.69	0.42	0.00	0.00	0.42	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	42.74	0.69	0.00	0.00	0.00	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	71.71	0.26	0.00	0.13	0.00	0.00	0.40	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	106.31	4.13	1.54	0.83	2.48	0.00	0.59	0.47	0.35	0.00
lung, fetal, donor1	10068-101I5	119.59	20.26	3.71	0.86	7.14	0.00	0.57	0.57	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	71.02	11.00	0.00	0.46	5.50	0.00	0.00	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	26.03	3.79	0.00	0.47	1.42	0.00	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	67.07	0.66	0.22	0.00	0.22	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.55	6.19	1.96	1.06	2.11	0.00	0.30	0.00	0.00	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	19.54	0.00	0.85	0.85	0.00	0.00	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	84.36	7.10	2.22	0.44	6.22	0.00	0.44	1.33	0.89	0.00
mature adipocyte, donor2	12232-129F9	104.80	2.91	0.62	0.62	1.87	0.00	0.42	1.66	0.83	0.00
mature adipocyte, donor3	12233-129G1	96.48	4.74	1.42	2.13	3.79	0.00	0.47	0.47	1.19	0.00
mature adipocyte, donor4	12234-129G2	57.64	3.69	0.79	1.05	4.21	0.26	0.53	0.79	1.32	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	84.82	29.31	11.44	5.00	10.96	0.24	3.10	6.19	6.67	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	57.53	4.51	3.38	0.00	1.13	2.26	0.00	3.38	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	39.91	2.39	1.84	0.55	2.39	0.92	0.18	0.55	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	74.97	4.77	2.54	2.86	5.08	0.95	0.64	0.64	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	19.62	2.13	1.71	2.56	1.28	11.09	0.85	1.28	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	57.54	6.58	1.86	2.53	4.05	4.56	0.51	2.03	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	32.26	2.97	0.42	0.64	3.18	0.64	0.42	1.06	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	42.38	1.93	3.85	1.93	9.63	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.56	3.95	6.10	3.95	0.72	9.33	0.36	2.15	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	51.27	11.68	3.24	2.60	2.60	3.89	1.30	1.30	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	43.96	5.57	2.63	1.86	4.49	5.88	0.46	1.39	1.70	0.00
medulla oblongata, adult, pool1	10038-101F2	55.42	7.51	4.65	3.84	4.08	3.02	0.73	0.98	1.06	0.24
medulla oblongata, newborn, donor10223	10361-105F1	31.94	6.94	3.47	4.86	3.47	1.74	0.00	0.35	2.08	0.35
medulloblastoma cell line:D283 Med	10838-111E1	43.40	0.22	0.22	0.00	0.00	0.00	0.00	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	15.77	0.73	0.37	0.00	0.37	0.00	0.24	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	26.16	28.46	12.94	6.90	14.66	0.00	0.43	0.43	0.29	0.57
melanoma cell line:G-361	10465-106H6	29.59	22.53	4.34	2.71	9.77	0.00	0.27	0.27	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	10.31	2.53	3.08	2.53	0.00	0.00	0.18	0.18	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	16.85	1.30	1.81	2.85	0.78	2.59	0.26	1.04	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	19.64	5.98	3.38	2.61	1.23	0.15	0.31	1.23	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.00	5.27	1.82	2.00	1.45	0.00	0.55	1.64	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	9.52	1.66	2.90	0.83	0.00	1.66	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	79.23	24.16	5.62	2.53	2.67	0.28	1.55	0.98	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	116.31	10.21	5.39	5.20	4.04	0.00	0.77	2.31	0.96	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	115.91	12.49	5.55	9.02	4.86	0.00	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.24	22.48	9.95	7.04	5.66	0.00	2.40	2.40	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	42.10	25.30	8.17	6.21	6.33	0.00	1.27	2.19	0.00	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.84	15.39	7.56	5.97	3.58	0.00	0.93	0.93	0.00	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.95	38.08	14.04	10.80	7.56	0.00	2.57	0.81	0.14	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	58.75	7.68	3.56	4.27	2.42	0.00	0.43	0.43	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.42	6.92	1.32	4.28	2.96	0.00	0.66	1.65	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	48.85	4.15	2.91	2.08	1.52	0.14	0.00	0.42	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	47.13	28.28	10.47	6.63	6.28	0.00	0.35	1.40	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	80.03	4.08	1.63	0.61	1.43	0.00	1.02	1.22	0.20	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	86.27	3.24	2.16	0.36	1.80	0.00	0.36	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	53.48	3.41	1.97	1.45	0.83	0.10	0.41	1.03	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	75.24	3.19	0.91	1.14	0.23	0.68	0.00	1.14	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	57.06	10.49	8.39	5.45	1.68	0.84	1.68	1.26	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	77.56	10.61	2.24	1.79	3.14	0.00	0.45	1.64	0.15	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.95	3.24	1.75	1.23	0.44	0.18	0.26	0.53	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	143.21	18.78	9.20	4.42	7.00	0.74	0.74	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	119.04	3.72	1.14	2.00	2.29	0.00	0.00	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	50.10	3.79	3.79	2.53	0.84	4.21	0.84	0.00	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.40	57.08	17.35	15.98	13.24	0.00	3.20	3.20	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	22.76	42.97	14.84	15.60	13.30	0.00	2.05	3.07	0.00	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.79	56.54	23.03	15.18	17.01	0.00	2.62	2.09	0.00	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.41	54.53	21.57	15.71	17.56	0.00	4.62	2.16	0.62	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	23.77	41.42	11.77	14.12	13.65	0.00	2.82	1.41	0.71	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.72	54.15	13.54	18.28	17.60	0.00	1.69	1.69	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.51	52.66	17.29	13.36	11.40	0.00	1.57	0.79	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.88	57.92	15.76	19.00	11.12	0.00	3.24	2.32	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.98	59.70	19.04	22.78	17.31	0.00	2.31	3.75	1.15	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.02	53.54	16.96	18.52	16.51	0.00	2.01	1.56	0.45	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	27.40	52.64	15.86	15.38	16.82	0.00	1.92	2.64	0.96	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.87	74.80	23.47	28.60	22.73	0.00	3.67	2.93	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	23.16	56.05	17.79	15.44	13.09	0.00	2.35	2.01	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.56	52.40	17.19	13.51	17.19	0.00	1.64	2.05	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.34	51.55	19.76	21.91	16.75	0.00	1.29	3.01	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	90.24	24.61	30.08	10.94	0.00	2.73	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	108.46	30.99	15.49	5.16	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	29.23	58.79	15.26	17.86	15.91	0.00	3.25	1.62	0.65	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	34.92	68.38	30.55	23.28	20.37	0.00	1.45	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.32	92.22	27.19	23.99	22.92	0.00	3.73	3.20	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	23.72	62.97	16.36	20.44	12.27	0.00	4.91	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	35.37	72.30	19.82	22.55	17.49	0.00	3.11	3.89	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	79.75	18.89	18.89	23.09	0.00	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	24.84	69.54	19.87	20.86	13.91	0.00	1.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	85.81	23.84	9.53	38.14	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	35.58	68.78	21.94	16.60	20.16	0.00	2.37	2.37	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	57.27	10.97	19.50	13.40	0.00	3.66	6.09	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	108.21	27.05	0.00	0.00	0.00	27.05	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	70.94	22.80	23.44	22.17	0.00	1.27	1.27	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	35.87	60.70	19.66	20.69	17.25	0.00	2.07	4.14	1.38	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	70.92	32.24	25.79	27.94	0.00	4.30	2.15	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	75.84	27.94	7.98	7.98	0.00	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	37.88	6.89	6.89	10.33	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.56	17.93	8.56	10.19	9.37	0.00	1.22	1.63	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	39.72	25.42	9.53	10.33	9.53	0.00	1.59	3.97	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.83	16.51	3.54	6.48	3.54	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.86	20.57	5.30	4.36	8.10	0.00	0.31	1.87	1.56	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	18.71	2.67	2.67	8.02	0.00	1.34	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	43.76	13.01	8.28	1.18	9.46	0.00	1.18	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	56.50	15.41	2.57	5.14	7.70	0.00	0.00	0.00	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	47.50	13.08	4.82	5.51	9.64	0.00	0.69	4.13	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.70	10.89	1.98	2.97	2.47	0.00	0.49	2.47	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	7.85	0.00	1.12	2.24	0.00	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.07	13.99	1.91	1.27	2.54	0.00	0.64	3.82	2.54	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.13	5.64	0.81	1.61	5.24	0.00	0.40	0.40	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	0.00	4.36	0.00	0.00	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	1.27	2.53	2.53	2.53	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	6.07	0.61	0.00	4.86	0.00	0.00	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	4.52	0.00	0.00	13.56	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	0.82	0.82	0.00	0.00	0.00	0.00	0.82	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	54.96	25.80	8.93	9.33	14.68	0.00	1.39	7.34	7.94	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.20	24.34	5.19	5.19	15.90	0.00	1.30	6.49	3.89	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	39.73	32.60	5.09	9.17	14.26	0.00	2.04	7.13	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	48.74	5.42	0.00	0.00	0.77	0.00	0.77	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	59.06	8.03	12.76	7.09	2.36	0.00	2.13	2.83	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.16	0.70	0.23	0.00	0.23	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	4.27	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.45	3.70	2.67	3.08	0.62	0.00	0.92	1.03	0.31	0.21
mesothelioma cell line:Mero-25	10850-111F4	14.07	1.82	2.50	0.45	0.68	0.00	0.23	0.91	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	40.34	9.29	3.42	1.96	2.93	0.00	0.49	2.20	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	36.76	5.54	5.31	4.21	1.11	0.00	1.33	0.66	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	43.36	3.94	1.05	0.26	0.79	0.00	0.26	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	36.77	6.81	3.57	1.87	2.55	0.00	0.85	1.19	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	32.30	2.28	0.00	0.62	0.83	0.00	0.41	0.41	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	30.81	5.47	4.80	4.14	1.49	0.00	0.66	0.99	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	16.11	1.45	0.54	0.18	0.72	0.00	0.00	0.00	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	35.70	8.37	4.78	4.78	2.05	0.00	0.51	0.17	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	49.62	0.76	0.25	0.76	1.02	0.00	0.00	0.25	1.02	0.00
mesothelioma cell line:No36	10857-111G2	13.05	5.87	4.24	1.96	0.98	0.00	0.98	0.98	0.65	0.98
mesothelioma cell line:ONE58	10858-111G3	33.33	1.35	0.54	0.81	0.27	0.00	0.00	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	2.49	0.00	0.58	0.19	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	6.11	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	14.90	0.54	0.00	0.00	0.00	0.00	0.00	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.06	0.98	0.98	0.33	0.33	0.00	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.45	1.27	1.06	0.64	0.42	0.00	0.21	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	15.66	0.00	1.15	0.00	0.46	0.00	0.00	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.61	0.38	0.00	0.19	0.19	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	39.18	2.77	1.11	0.74	0.37	0.00	0.18	0.55	0.00	0.18
myeloma cell line:PCM6	10474-106I6	10.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.41	10.15	10.65	1.01	4.06	0.00	0.51	1.01	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	39.42	159.66	82.38	36.09	46.68	0.00	7.26	0.78	0.39	1.96
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.16	0.22	0.22	0.11	0.00	0.00	0.11	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.72	0.15	0.15	0.37	0.15	0.00	0.00	0.15	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	32.57	0.55	0.55	0.55	0.00	0.00	0.00	2.76	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	45.32	0.00	0.23	0.00	0.00	0.46	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	40.04	4.49	5.43	2.43	1.87	8.79	0.75	1.12	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	11.18	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	34.10	0.93	0.19	0.93	0.37	0.00	0.19	0.56	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.38	0.00	0.24	0.00	0.24	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	19.52	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	67.87	25.29	12.24	6.65	6.12	0.00	1.60	0.27	0.00	1.60
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	83.71	0.34	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	3.20	9.61	7.20	0.80	156.90	4.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	57.71	23.72	8.98	3.53	12.82	0.00	1.28	1.28	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	71.73	2.89	0.79	0.26	0.53	0.00	0.00	0.53	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	128.24	4.59	4.87	5.06	2.53	6.19	1.12	2.53	1.31	0.19
occipital cortex - adult, donor10196	10172-103C1	74.17	18.54	4.12	6.18	4.12	2.06	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	51.26	3.22	0.54	0.54	4.56	0.00	0.00	0.54	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	21.84	4.00	3.64	4.73	3.28	4.73	2.18	2.18	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	85.80	8.92	3.94	2.36	5.77	1.84	1.57	0.79	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	50.20	3.43	4.29	3.00	3.00	2.57	0.86	1.29	0.43	0.86
occipital pole, adult, pool1	10036-101E9	90.12	8.04	4.18	2.76	3.23	1.73	1.02	1.18	0.39	0.16
olfactory region, adult	10195-103E6	44.52	5.16	1.91	0.96	2.67	4.20	0.76	0.57	0.96	0.19
optic nerve, donor1	10277-104E7	38.02	26.01	44.02	8.00	4.00	0.00	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.06	0.80	1.48	1.25	0.00	0.00	0.23	0.46	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.43	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.40	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	94.95	5.29	2.06	5.59	2.35	0.29	0.29	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	28.96	33.64	12.15	5.61	0.00	0.00	0.93	0.00	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	48.35	2.12	0.00	0.42	0.64	0.00	0.00	0.21	0.00	0.21
ovary, adult, pool1	10020-101D2	77.48	9.43	2.97	1.66	5.50	0.00	0.70	2.71	3.23	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	52.80	0.55	0.37	0.37	0.00	0.00	0.00	0.55	0.00	0.18
pancreas, adult, donor1	10049-101G4	61.14	25.40	1.88	0.94	14.11	11.29	0.00	3.76	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	34.75	2.04	1.70	0.51	0.85	0.00	0.34	0.17	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	46.36	0.50	0.17	0.33	0.00	0.00	0.00	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	80.45	7.60	4.76	3.20	3.57	2.84	1.37	0.92	0.73	0.09
parietal cortex, adult, donor10258	10373-105G4	105.70	3.67	5.87	3.67	2.20	0.00	0.73	0.73	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	53.61	3.76	3.76	0.94	8.46	3.76	0.00	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	49.31	3.71	0.57	1.43	1.71	0.86	0.00	1.14	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	75.34	5.46	3.26	2.64	3.26	1.67	0.79	1.23	0.35	0.00
parietal lobe, fetal, donor1	10072-101I9	73.71	12.61	7.76	1.94	0.97	1.94	1.94	2.91	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	25.05	2.99	4.49	2.24	1.87	4.86	1.12	2.24	1.12	0.00
parotid gland, adult	10199-103F1	167.12	12.33	0.62	0.00	17.27	0.00	0.00	2.47	0.62	0.00
penis, adult	10200-103F2	89.70	12.35	6.98	8.59	11.28	0.00	2.15	5.91	3.22	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.82	0.00	0.56	0.93	0.00	1.12	0.00	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	51.72	5.10	0.29	0.44	2.77	0.00	0.15	0.73	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	31.61	113.52	159.32	89.66	39.35	4.52	27.09	9.68	3.23	1.29
pineal gland, adult, donor10252	10160-103A7	34.94	20.73	11.25	15.40	12.44	0.00	6.51	3.55	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	40.76	68.98	64.59	64.59	22.57	0.00	17.56	10.03	5.64	0.63
pituitary gland - adult, donor10196	10180-103C9	136.59	46.54	51.60	7.08	15.18	47.55	13.15	7.08	9.11	0.00
pituitary gland, adult, donor10252	10162-103A9	179.81	25.54	10.42	11.47	11.47	31.27	6.78	10.42	11.47	1.04
pituitary gland, adult, donor10258	10378-105G9	116.62	26.39	11.92	3.40	8.51	22.13	5.11	14.47	10.21	0.00
placenta, adult, pool1	10021-101D3	166.63	3.01	2.47	2.26	1.08	0.00	0.65	0.54	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	23.17	0.26	0.00	0.13	0.26	0.00	0.00	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	93.54	3.58	0.78	1.09	1.25	0.00	0.62	1.56	1.40	0.00
pons, adult, pool1	10033-101E6	69.97	14.80	12.91	9.90	6.02	1.03	1.12	2.24	1.72	0.17
postcentral gyrus, adult, pool1	10032-101E5	83.43	6.80	2.96	2.53	3.84	2.09	0.78	1.74	0.70	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	54.38	0.00	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	63.95	2.77	2.48	1.75	0.73	0.00	0.44	0.15	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	67.16	2.72	3.09	3.27	1.45	0.00	0.36	1.27	0.00	0.18
prostate, adult, pool1	10022-101D4	74.28	10.79	2.90	2.18	6.62	0.54	0.45	1.72	1.90	0.27
putamen, adult, donor10196	10176-103C5	129.60	2.60	6.14	4.25	2.12	13.69	1.89	8.97	0.71	0.00
putamen, adult, donor10252	10152-102I8	92.15	0.00	5.88	5.88	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	93.98	3.28	5.46	5.46	1.09	1.09	0.00	1.09	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	181.21	3.62	8.70	6.28	2.90	2.42	1.21	3.38	0.72	0.00
putamen, newborn, donor10223	10365-105F5	46.48	1.50	3.00	4.50	0.00	5.25	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	23.86	1.45	0.58	0.58	1.16	0.00	0.29	0.29	0.29	0.29
rectum, fetal, donor1	10067-101I4	72.33	36.17	5.56	2.78	12.52	11.13	1.39	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	132.07	2.54	0.64	0.42	0.85	0.00	0.00	1.06	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	119.71	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	60.53	6.76	1.39	1.89	4.57	0.20	0.50	1.19	2.39	0.10
retinoblastoma cell line:Y79	10475-106I7	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	21.09	3.37	1.12	0.84	0.28	0.00	0.28	1.12	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	53.81	11.37	3.79	2.27	0.00	0.00	0.00	0.76	0.00	1.52
salivary acinar cells, donor1	11771-123I7	26.38	0.16	0.00	0.16	0.16	0.00	0.00	0.32	0.00	0.00
salivary acinar cells, donor2	11772-123I8	21.34	1.38	0.41	0.41	0.41	0.00	0.00	0.41	0.00	0.00
salivary acinar cells, donor3	11773-123I9	27.14	1.32	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	419.81	54.91	4.00	1.14	25.17	0.00	0.00	1.14	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	32.54	8.60	11.04	5.40	4.22	0.17	3.12	1.01	0.00	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	30.21	9.05	9.99	5.76	4.70	0.47	2.70	0.94	0.24	0.71
seminal vesicle, adult	10201-103F3	55.02	17.46	3.17	1.59	12.70	0.00	0.53	3.17	6.88	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	19.19	0.97	0.49	0.00	0.00	0.00	0.00	0.49	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	48.31	0.25	2.52	3.27	0.00	0.00	0.75	0.50	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	3.01	2.01	5.02	3.01	0.00	0.00	0.00	0.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	6.04	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	18.32	0.39	0.00	0.13	0.13	0.00	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	52.49	16.31	15.61	4.26	6.38	0.00	1.42	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	90.67	21.11	23.87	7.20	9.95	0.12	3.00	0.72	0.96	0.36
skeletal muscle, fetal, donor1	10066-101I3	21.11	25.13	8.04	7.04	4.02	0.00	3.02	7.04	2.01	0.00
skin, adult, donor1	10074-102A2	81.42	61.07	13.57	6.79	40.71	0.00	0.00	6.79	6.79	0.00
skin, fetal, donor1	10065-101I2	35.98	30.30	9.47	4.42	10.10	0.00	0.63	1.89	5.05	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.35	3.34	2.67	0.67	1.00	0.67	0.00	0.33	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	22.06	0.00	0.00	0.00	0.00	6.93	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.22	0.19	0.00	0.00	0.00	0.00	0.00	0.19	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	28.52	13.52	18.46	19.28	5.27	0.33	2.64	3.63	4.62	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	21.39	0.16	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	45.54	4.58	9.37	4.14	1.53	280.46	0.87	1.31	0.00	0.00
small intestine, adult, pool1	10024-101D6	67.84	4.78	0.60	0.60	2.63	4.18	0.00	0.60	0.60	0.36
small intestine, fetal, donor1	10064-101I1	55.28	9.34	0.25	0.74	2.46	6.39	0.00	0.49	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.36	35.39	25.65	44.11	18.98	189.26	9.75	7.18	6.15	0.00
smooth muscle, adult, pool1	10048-101G3	66.68	17.06	2.33	2.58	9.82	0.00	0.00	3.88	2.07	0.00
somatostatinoma cell line:QGP-1	10781-110G7	75.85	18.49	10.45	12.33	7.77	34.31	3.75	2.41	2.14	1.07
spinal cord - adult, donor10196	10181-103D1	25.23	9.86	2.52	0.92	4.59	1.15	0.23	0.46	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	37.85	2.76	0.39	0.79	1.58	1.58	0.00	0.79	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	32.51	5.53	2.77	2.08	1.38	2.08	0.00	1.38	4.84	0.00
spinal cord, fetal, donor1	10056-101H2	46.96	20.73	4.88	3.66	3.66	2.44	0.00	3.66	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	28.01	3.21	3.21	0.46	2.30	1.38	0.46	0.46	2.30	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	76.62	33.46	11.95	7.77	6.57	0.00	1.94	0.30	0.15	0.75
spleen, adult, pool1	10025-101D7	58.48	2.20	0.66	0.11	1.21	0.00	0.00	0.33	0.55	0.11
spleen, fetal, pool1	10044-101F8	62.45	4.21	1.19	0.32	1.59	0.00	0.00	0.32	1.19	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	30.74	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.60	0.38	0.00	0.19	0.38	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.10	32.15	23.76	5.24	9.09	0.00	3.49	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.07	0.39	1.17	0.39	0.00	0.00	0.78	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.76	0.11	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	52.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	38.45	10.68	0.00	3.20	7.48	4.27	0.00	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	284.27	17.66	1.71	1.71	10.25	0.00	0.00	1.71	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.77	1.87	0.21	0.42	1.66	0.00	0.42	0.83	0.83	0.00
substantia nigra, adult, donor10258	10371-105G2	63.62	18.62	8.28	8.79	9.31	1.55	1.55	3.62	3.10	0.00
substantia nigra, newborn, donor10223	10358-105E7	28.26	4.95	1.41	1.41	3.53	0.00	0.00	0.71	3.53	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	109.59	10.55	4.81	3.44	3.67	0.00	1.60	1.60	7.11	0.69
temporal lobe, adult, pool1	10031-101E4	75.70	4.24	3.48	2.63	2.97	4.15	0.59	2.03	0.42	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	35.61	0.71	0.71	2.85	2.14	1.42	2.85	0.71	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	37.36	3.96	1.76	0.44	0.44	0.00	0.88	0.44	0.88	0.00
tenocyte, donor1	11763-123H8	80.29	24.44	5.59	3.49	9.43	0.00	2.44	3.84	0.70	0.00
tenocyte, donor2	11765-123I1	109.11	34.34	16.79	10.30	14.50	0.00	2.29	4.96	1.14	0.76
tenocyte, donor3	11768-123I4	57.82	32.25	13.71	8.15	8.15	0.00	3.71	4.08	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	4.59	1.36	1.19	1.19	0.68	0.00	0.34	0.68	1.19	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	24.51	0.00	0.00	0.00	0.00	1.54	0.00	0.00	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	27.59	3.72	4.34	1.24	0.46	0.00	0.46	1.70	1.39	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8.89	1.78	2.92	1.27	0.38	0.00	1.02	0.51	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	4.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.33	0.00	0.00
testis, adult, pool1	10026-101D8	49.18	13.96	4.19	2.79	8.91	0.00	0.64	3.01	2.58	0.32
testis, adult, pool2	10096-102C6	16.24	11.73	6.77	0.00	6.32	0.00	0.00	0.90	0.90	0.90
thalamus - adult, donor10196	10168-103B6	50.78	15.46	6.62	5.52	6.62	0.00	1.10	2.21	0.00	1.10
thalamus, adult, donor10252	10154-103A1	37.35	3.13	1.25	1.41	1.09	0.31	0.16	0.31	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	72.36	15.40	4.62	4.62	27.71	1.54	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	60.77	21.41	4.94	4.94	11.86	0.33	1.32	1.98	0.99	0.33
thalamus, newborn, donor10223	10366-105F6	24.74	6.33	9.78	14.38	3.45	1.73	2.30	2.30	0.58	0.00
throat, adult	10209-103G2	59.92	15.98	5.49	1.25	6.99	0.00	3.25	1.75	2.25	0.25
throat, fetal, donor1	10061-101H7	53.93	24.38	4.88	4.27	13.41	0.91	0.61	1.83	4.57	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	55.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.40	0.20
thymus, adult, pool1	10027-101D9	11.93	0.70	0.70	0.20	0.50	0.10	0.00	0.10	0.30	0.10
thymus, fetal, pool1	10043-101F7	33.87	2.39	1.04	0.62	0.94	0.21	0.00	0.31	0.31	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	74.86	3.06	2.39	2.13	0.80	0.00	0.53	0.27	0.00	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	104.91	6.84	5.73	2.65	2.65	0.00	0.42	0.56	0.00	0.28
thyroid, adult, pool1	10028-101E1	167.40	5.13	2.33	0.37	2.80	0.00	0.37	0.93	0.56	0.47
thyroid, fetal, donor1	10060-101H6	59.85	16.87	1.85	1.05	6.86	0.00	0.26	2.11	1.58	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	107.79	18.48	6.16	3.08	15.40	0.00	0.00	3.08	6.16	0.00
tongue, adult	10203-103F5	50.00	10.47	5.58	2.09	7.68	0.00	1.86	2.09	2.09	0.47
tongue, fetal, donor1	10059-101H5	53.60	20.89	10.25	4.73	13.40	0.00	2.76	3.94	6.31	1.58
tonsil, adult, pool1	10047-101G2	49.79	5.61	1.50	0.50	5.31	0.00	0.00	0.80	1.80	0.50
trachea, adult, pool1	10029-101E2	90.31	26.58	2.86	1.80	12.84	0.16	0.57	0.98	1.88	0.41
trachea, fetal, donor1	10058-101H4	65.40	49.24	12.31	5.77	26.93	0.38	2.31	4.23	6.54	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.82	10.27	1.42	0.71	4.25	0.00	0.00	0.35	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	26.34	1.11	0.81	0.81	0.20	0.00	0.00	0.00	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	83.20	8.93	6.11	3.13	3.13	0.00	0.94	1.10	0.16	0.78
tridermal teratoma cell line:HGRT	10694-109G1	60.88	22.83	13.32	3.81	3.81	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.75	3.30	0.59	0.85	0.85	0.00	0.08	0.42	0.25	0.51
umbilical cord, fetal, donor1	10057-101H3	41.73	58.42	33.38	6.26	18.78	0.00	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	116.03	32.76	8.36	7.34	14.16	0.00	2.05	4.27	11.09	0.51
uterus, fetal, donor1	10055-101H1	102.90	31.23	7.17	4.10	12.80	0.00	2.56	5.63	15.87	1.02
vagina, adult	10204-103F6	63.33	10.99	1.94	0.00	6.46	0.00	0.65	1.94	0.00	0.00
vein, adult	10191-103E2	44.72	19.07	6.80	2.41	9.64	0.22	1.97	2.41	3.51	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00